Skip Navigation Bar

History of Medicine Finding Aids

Medical Library Association Archives 1898-2002
full text File Size: 1883 K bytes | Add this to my bookbag

 
Box | Folder Title
 
Research Data PET scans, 1971-1981, n.d. [subseries]:
 
Numbered
50 1
1 autoradiograph with standard [photographs, negative], n.d.
50 2
2 DG + DG2 + MG molecules [photographs, negative], n.d.
50 3
3 DG through brain barrier [photographs, negative], n.d.
50 4
4 functional anatomy of operational - *DG equ. [photographs, negative], n.d.
50 5
5 lumped constant in several species [photographs, negative], n.d.
50 6
6 glucose utilization in conscious rat and monkey [photographs, negative], n.d.
50 7
7 effects of thiopental anesthesia on cerebral glucose utilization [photographs, negative], n.d.
50 8
8 spinal cord effects of unilateral stimulation [photographs, negative], n.d.
50 9
9 relationship between frequency of stimulation and LGU [photographs, negatives, slides], n.d.
50 10
10 focal seizure during LGU [photographs, negatives], n.d.
50 11
11 otitis [photographs, negatives], n.d.
50 12
12 left eye removed (rat) L.G.U. [photographs, negatives], n.d.
50 13
13 coronal brain (monkey) [photographs, negatives], n.d.
50 14
14 coronal brain (monkey) -- rt. eye occluded, n.d.
50 15
15 [negative], n.d.
50 16
16 12 hr. lt./12 hr. dk. (glucose utilization) [photographs, negative], n.d.
50 17
17 apomorphine rt. eye enucleated [photographs, negative], n.d.
50 18
18 effects of d- and 1- amphetamine on LCGU in rat [photographs, negative], n.d.
50 19
19 computer diagram image display system [photographs, negative], n.d.
50 20
20 average brain cerebral glucose utilization [negative], n.d.
50 21
21 ageing and metabolism [photographs, negative], n.d.
50 22
22 ageing and metabolism [photographs, negative], n.d.
50 23
23 ageing and metabolism, LCGU vs. apomorphine [photographs, negative], n.d.
50 24
24 ageing, LCGU vs. apomorphine [photographs, negative], n.d.
50 25
25 LCGU vs. aopmorphine (subthalamic nucleus and inferior olivary nucleus) [photographs, negative], n.d.
50 26
26 LCGU vs. apomorphine (ageing) [photographs, negative], n.d.
50 27
27 DG, FDG, CH3 -- glucose, brain pictures [photographs, negative], n.d.
50 28
28 glucose metabolic rate (FDG) [photographs, negative], n.d.
50 29
29 LCGU vs. apomorphine (age), n.d.
50 30
30 LCBF w/[I125] Hipdm vs. [C14} idoantipyrine [photographs, negative], n.d.
50 31
31 LCBF indicator fraction method [photographs, negative], n.d.
50 32
32 spreading depression [photographs, negative], n.d.
50 33
33 [photographs, negative], n.d.
50 34
34 electrical stimulation and DG* uptake in pituitary [negative], n.d.
50 35
35 socium pump and neurosecretion effects on DG* uptake [photographs, negative], n.d.
50 36
36 [125] hipdm and products vs. radioactivity in arterial blood [photographs, negative], n.d.
50 37
37 radioactivity DPM vs. time curves [photographs, negative], n.d.
50 38
38 spreading cortical depression (KCI) [photographs, negative], 1981
50 39
39 osmotic opening of BBB [photographs, negative], n.d.
50 40
40 blood flow vs. LGU in conscious and anesthetized [photographs, negative], n.d.
50 41
41 [photographs, negative], n.d.
50 42
42 glucose utilization in dark-adapted rats (saline vs. apomorphine) [photographs, negative], n.d.
50 43
43 dark-adapted rats (eye enucleated) saline vs. apomorphine [photographs, negative], n.d.
50 44
44 effects of light intensity on LGU [photographs, negative], n.d.
50 45
45 [125I] hipdm single pass extraction vs. venous [photographs, negative], n.d.
50 46
46 deosyglucose vs. glucose in arterial and venous [photographs, negative], n.d.
50 47-48
47 influence of rate constants on integrated pool specific activity [photographs, negative], n.d.
50 49
48 rate constants in the normal conscious albino rat [negative], n.d.
50 50
49 lump constant vs. time [photographs, negative], n.d.
50 51
50 cerebral metabolism of [14C] DG and G in vivo [photographs, negative], n.d.
50 52
51 blood CO2 curves [photographs, negative], n.d.
50 53
52 striate cortex (monkey) [photographs, negative], n.d.
50 54
53 autoradiograph dorsolateral surface of monkey occipital lobe [photographs, negative], n.d.
50 55
54 LCGU vs. apomorphine [photograph, negative, slides], n.d.
50 56
55 systems involved in higher functions [negative], n.d.
50 57
56 auditory system (LCGU) [negative], n.d.
50 58
57 auxtomy, leucine protein synthesis [photographs, negative], n.d.
50 59
58 auxtomy, DG, protein synthesis nissl stain [photographs, negative], n.d.
50 60
59 3H and 24C DG [photographs, negative], n.d.
50 61
60 brain anatomy labeled [photographs, negative], n.d.
50 62
61 experimental period effects on gray matter glucose utilization [photographs, negative], n.d.
50 63
62 visual stimulus (3H] DG [photographs, negative], n.d.
50 64
63 pretectal nucleus [photographs, negative], n.d.
50 65
64 visual cortex [photographs, negative], n.d.
50 66
65 lateral geniculate nucleus [photographs, negative], n.d.
50 67
66 posterolateral nucleus of the thalamus [photographs, negative], n.d.
50 68
67 blood flow vs. LCGU (control) [photographs, negative], n.d.
50 69
68 blood flow vs. LCGU (acidosis) [photographs, negative], n.d.
50 70
69 blood flow vs. LCGU (acidosis and control) [photographs, negative], n.d.
50 71
70 antidromic stimulation of superior cervical ganglion [photographs, negative], n.d.
50 72
71 superior colliculus LCGU vs. light intensity [photographs, negative], n.d.
50 73
72 *DG and *DG-6-phosphate concentration over time [photographs, negative], n.d.
50 74
73 antidomic stimulation of superior cervical ganglion [photographs, negative], n.d.
50 75
74 antidromic stimulation of superior cervical ganglion [photographs, negative], n.d.
50 76
75 air embolism and control in K+ concentration [photographs, negative], n.d.
50 77
76 air embolism and control in pH of injection fluid [photographs, negative], n.d.
50 78
78 post axotomy and control [photographs, negative], n.d.
50 79
80 [photographs, negative], n.d.
50 80
81 hypoxemia [photographs, negative], n.d.
50 81
82 darkness vs. 700 lux (pigmented rats) [photographs, negative], n.d.
50 82
83 hypoxemia [photographs, negative], n.d.
50 83
84 hypoxemia [photographs, negative], n.d.
50 84
85 darkness vs. 700 lux (albino rats) [photographs, negative], n.d.
50 85
86 newborn monkey [photographs, negative], n.d.
50 86
87 [photographs, negative], n.d.
50 87
88 spinal cord [photographs, negative], n.d.
50 88
89 globus pallidus, etc. [negative], n.d.
50 89
90 reginal glucose utilization [photographs, negative], n.d.
50 90
91 reginal glucose metabolism after 10 min. cerebral ischemia in the rat [photographs, negative], n.d.
50 91
92 [photograph], n.d.
50 92
93 left eye removed [photographs, negative], n.d.
50 93
94 penn. seizure antipyrine, baby monkey [photographs, negative], n.d.
50 94
95 effects of thiopental anesthesia on cerebral glucose utilization [photograph], n.d.
50 95
97 equilibration of glucose specific activity between plasma and brain [photographs, negative], n.d.
50 96
98 influence of duration on glucose utilization [photographs, negative], n.d.
50 97
99 relationship between stimulation and L.G.U. [photographs, negative], n.d.
50 98
100 determination of glucose specific activity [photographs, negative], n.d.
50 99
101 brain-plasma glucose equilibration, n.d.
50 100
102 tissue glucose pool ½ life vs. plasma glucose concentration [photographs, negative], n.d.
50 101
103 glucose activity in plasma, tissue [negative], n.d.
50 102
104 cerebral 02 consumption in cerebral blood flow [photographs, negative], n.d.
50 103
105 half-lives of DG*-6-P in grey and white matter [photographs, negative], n.d.
50 104
106 arterial and venous [ ] of 14c D.G. following i.v. in a cat [photographs, negative], n.d.
50 105
107 derivation of operational method for measurement of LCGU [photographs, negative], n.d.
50 106
108 tissue pool ½ life [photographs, negative], n.d.
50 107
109 math. analysis of model for total accumulation of DG* and DG*-P [photograph, negative], n.d.
50 108
110 theoretical calculation of [14c] DG-6-P in rat brain [photographs], n.d.
50 109
111 general equation + influence of phosphotase activity [photograph, negative], n.d.
50 110
112 lumped constant calculation used by Hawkins and Miller [photographs], n.d.
50 111
113 [photograph], n.d.
50 112
114 equation for changing plasma glucose concentration [photograph, negative], n.d.
50 113
115 BBB model and equation of 14C glucose uptake [photograph, negative], n.d.
50 114
116 glucose uptake model + equation [photographs, negative], n.d.
50 115
117 LCGU in conscious albino and pigmented rats [negative], n.d.
50 116
118 glucose utilization in sensorimotor systems [negative], n.d.
50 117
119 glucose utilization in myelinated fiber tracts [negative], n.d.
50 118
120 glucose utilization in limbic system [negative], n.d.
50 119
121 glucose utilization in conscious and restrained rats [negative], n.d.
50 120
122 glucose utilization of the visual system [negative], n.d.
50 121
123 ½ life of tissue pool in male rats [negative], n.d.
50 122
124 turnover of tissue glucose pool in male rats [negative], n.d.
50 123
125 values of rate constants in normal conscious albino rats [photographs, negative], n.d.
50 124
127 conditions w/altered function in CNS w/out change in average body metabolism [photograph], n.d.
50 125
128 relationship between consciousness and cerebral metabolic rate [photograph], n.d.
50 126
129 sodium pump and neurosecretion effects on DG* uptake, n.d.
50 127
130 functional anatomy of the DG*method equ. [photographs, negative, slide], n.d.
50 128
131 operational equation of [14C] DG method [photographs, negatives], n.d.
50 129
132 plasm -- tissue B-B-B (revised by Smith) [photographs, negatives], n.d.
50 130
135 LCBF with hipdm indicator fractionation method [photographs, negatives], n.d.
50 131
136 [14c] glucose-6-P single pass extraction fraction [photographs, negatives], n.d.
50 132
137 LCBF w/[I125] hipdm tissue equilibration method [photographs, negatives], n.d.
50 133
138 retinal stimulation in rats [photographs, negatives], n.d.
50 134
139 local cerebral glucose utilization [photographs, negatives], n.d.
50 135
140 local cerebral blood flow [photographs, negatives], n.d.
50 136
141 kinetics of competitive substrate reactions [photographs, negatives], n.d.
50 137
142 CBF and CMR 02 vs. years [photographs, negatives], n.d.
50 138
143 influence of CO2 in correlation between LCBF and LCGU [photographs, negatives], n.d.
50 139
144 monkey [photographs, negatives], n.d.
50 140
145 glucose utilization vs. stimulation frequency [photographs, negatives], n.d.
50 141
146 operational equation of [14C] deoxyglucose method [photograph], n.d.
50 142
147 cervical ganglion drawing [photographs, negatives], n.d.
51 1
148 cervical ganglion drawing [photographs, negatives], n.d.
51 2
149 cervical ganglion (micro) [photographs, negatives], n.d.
51 3
150 effects of apomorphine upon glucose utilization in habenula [photographs, negatives], n.d.
51 4
151 LCGU vs. halperidol [photographs, negatives], n.d.
51 5
152 LCGU vs. apomorphine [photographs, negatives], n.d.
51 6
153 preanglionic holinergic fibers [photographs, negatives], n.d.
51 7
154 pre-ganglionic cholinergic [photographs, negatives], n.d.
51 8
155 focal seizures - protein synthesis [photographs, negatives], n.d.
51 9
156 focal seizures (metabolic effects) [photographs, negatives], n.d.
51 10
157 optical density, apomorphine vs. halperidol [photographs, negatives], n.d.
51 11
158 apomorphine vs. haloperidol (magnification) [photographs, negatives], n.d.
51 12
159 slide to side differences in monkey brain structures [photographs, negatives], n.d.
51 13
160 LGU in monkey brain [photographs, negatives], n.d.
51 14
161 influence of age on responsiveness to apomorphine [photographs, negatives], n.d.
51 15
162 influence of age on responsiveness to apomorphine (zona compacta) [photographs, negatives], n.d.
51 16
163 influence of age on responsiveness to apomorphine (aged 48-67) [photographs, negatives], n.d.
51 17
164 cervical ganglion [photographs, negatives], n.d.
51 18
165 regional glucose utilization [photographs, negatives], n.d.
51 19
166 regional glucose utilization (ketamine) [photographs, negatives], n.d.
51 20
167 regional glucose utilization (limbic system) [photographs, negatives], n.d.
51 21
168 regional glucose utilization: auditory, visual, sensory [photographs, negatives], n.d.
51 22
169 physiologic parameters [photographs, negatives], n.d.
51 23
170 LCGU (percentage change from control) [photographs, negatives], n.d.
51 24
171 LCGU (percentage change from control) ketamine [photographs, negatives], n.d.
51 25
172 blood flow transport and metabolism [photographs, negatives], n.d.
51 26
173 SSA vs. 1/[GHB] [photographs, negatives], n.d.
51 27
174 SSA or NADPH vs. 1/[NADP+] [photographs, negatives], n.d.
51 28
175 SSA or NADPH vs. time [photographs, negatives], n.d.
51 29
176 1/[GHB] vs NADPH, NADPH vs. 1/[NADPH] [photographs, negatives], n.d.
51 30
177 NADPH vs. 1/[NADPH] and 1/[GHD] [photographs, negatives], n.d.
51 31
178 SA vs. [GHB] and [D-glucuronate] [photographs, negatives], n.d.
51 32
179 apomorphine substantia nigra young vs. aged rats [photographs, negatives], n.d.
51 33
180 monocular deprivation (neonatal monkey) [photographs, negatives], n.d.
51 34
181 naftidro furyl [photographs, negatives], n.d.
51 35
182 hypoxemia metabolic raes [photographs, negatives], n.d.
51 36
183 lateral genic (monkey) [photographs, negatives], n.d.
51 37
184 ketamine [photographs, negatives], n.d.
51 38
185 norepinephrine vs. LCGU [photographs, negatives], n.d.
51 39
186 norepinephrine vs. control LCGU [photographs, negatives], n.d.
51 40
187 LCGU in white matter during hypoxemia [photographs, negatives], n.d.
51 41
188 awake/asleep, striate cortex and sensory-motor cortex [photographs, negatives], n.d.
51 42
189 lumped constant vs. plasma glucose [photographs, negatives], n.d.
51 43
190 superior cervical ganglia/glucose utilization [photographs, negatives], n.d.
51 44
191 coeliac and cardiac ganglia/glucose utilization [photographs, negatives], n.d.
51 45
192 hexokinase synthesis chart [photographs, negatives], n.d.
51 46
193 physiological variables in hypoxemia [photographs, negatives], n.d.
51 47
194 average rate of G.U. in whole brain during hypoxemia [photographs, negatives], n.d.
51 48
195 captopril effects on G. U. of subfornical organ in Brattleboro rats [photographs, negatives], n.d.
51 49
196 deoxyglucose autoradiographs of cat lumbar spinal cord [photographs, negatives], n.d.
51 50
197 lumbar spinal cord + brain autoradiographs and stained [photographs, negatives], n.d.
51 51
198 hyperglycemia lumped constant [photographs, negatives], n.d.
51 52
199 time course of arterial and venous concentrations of DG* and G [photographs, negatives], n.d.
51 53
200 model for behavior of leucine in brain [photographs, negatives], n.d.
51 54
201 glucose clamp [photographs, negatives], n.d.
51 55
202 lumped constant at different plasma glucose levels, n.d.
51 56
203 conversion of leucine to acetoacetic acid and acetyl-coenzyme A [photographs, negatives], n.d.
51 57
204 metabolic rates during hypoxemia [photographs, negatives], n.d.
51 58
205 axotomy hypoglossal nucleus [photographs, negatives], n.d.
51 59
206 derivation of operational equ.-model I [photographs, negatives], n.d.
51 60
207 behavior of leucine in brain model [photographs, negatives], n.d.
51 61
208 differential equations leucine [photographs, negatives], n.d.
51 62
209 behavior of leucine in brain model 2 [photographs, negatives], n.d.
51 63
210 differential equations leucine II [photographs, negatives], n.d.
51 64
211 derivation of operational equ. -- model III [photographs, negatives], n.d.
51 65
212 leucine brain -- model III [photographs, negatives], n.d.
51 66
213 differential equations model III [photographs, negatives], n.d.
51 67
214 derivation of operational equ. model III [photographs, negatives], n.d.
51 68
215 derivation of operational equ. III continued [photographs, negatives], n.d.
51 69
216 derivation of equation [photographs, negatives], n.d.
51 70
217 model IV -- amino acid incorporation into protein [photographs, negatives], n.d.
51 71
218 derivation of operational equ. model IV [photographs, negatives], n.d.
51 72
219 derivation of operational equ. -- model IV continued [photographs, negatives], n.d.
51 73
220 lumped constant in hypoglycemia [photographs, negatives], n.d.
51 74
221 DG model -- intracellular and extracellular spaces [photographs, negatives], n.d.
51 75
222 LCGU kates of insulin-induced hypoglycemia rats [photographs, negatives], n.d.
51 76
224 physiological variables during insulin-induced hypoglycemia [photographs, negatives], n.d.
51 77
225 determination of the ½ life of the precursor leucine pool [photographs, negatives], n.d.
51 78
226 synthesis and catabolism of histamine, n.d.
51 79
227 determination of activity of L-leucine and TRNA-bound leucine [photographs, negatives], n.d.
51 80
228 scheme for oxidation of [ ]-droxybutyrate/reduction of D-glucuranate [photographs, negative], n.d.
51 81
229 superior cervical ganglia (G.U. vs. time) [photographs, negative], n.d.
51 82
230 synaptic mechanisms for histamine neurons [photographs, negative], n.d.
51 83
231 visual cortex of monkey [photographs], n.d.
51 84
232 fetal sheep [photographs, negative], n.d.
51 85
233 fetal sheep? [photographs, negative], n.d.
51 86
234 saphenous nerve stimulation during anesthesia [photographs, negative], n.d.
51 87
235 monkey columns [photographs, negative], n.d.
51 88
236 norepinephrine vs. control LCGU [photographs, negative], n.d.
51 89
237 autoradiographic resolutions [photographs, negative], n.d.
51 90
239 layer thickness 3H activity [photographs, negative], n.d.
51 91
240 LandR hemisphere [photographs, negative], n.d.
51 92
241 functional anatomy of the operational equ. of the 14c DG method [photographs, negative], n.d.
51 93
242 [photographs, negative], n.d.
51 94
243 [photographs, negative], n.d.
51 95
244 [photographs, negative], n.d.
51 96
245 olfactory bulbs [photographs, negative], n.d.
51 97
246 relative optical density [photographs, negative], n.d.
51 98
247 hot hole plug [photographs, negative], n.d.
51 99
248 brain standards 3H and 14c [photographs, negative], n.d.
51 100
249 goldfish retinas [photographs, negative], n.d.
51 101
250 somata cells labeled and unlabeled [photographs, negative], n.d.
51 102
251 cat muscle, 24c DG [photographs, negative], n.d.
51 103
252 3H DG water solution frozen in plasma [photographs, negative], n.d.
51 104
253 grain density in buccal ganglion [photographs, negative], n.d.
51 105
254 olfactory bulb in tiger salamander 3HDG [photographs, negative], n.d.
51 106
255 3HDG -- optic lobes of drosophila melanogaster [photographs, negative], n.d.
51 107
256 relationship of aggression to onset of lidocaine seizures [photographs, negative], n.d.
51 108
257 autoradiographic calibration curves vs 3H concentration [photographs, negative], n.d.
51 109
258 [photographs, negative], n.d.
51 110
259 ocular dominance newborn [photographs, negative], n.d.
51 111
260 position-emitting atom [photographs, negative], n.d.
51 112
261 [14C] and [3H] methylglucose [photographs, negative], n.d.
51 113
262 mid and posterior hypothalamus [photographs, negative], n.d.
51 114
263 anterior hypothalamus [photographs, negative], n.d.
51 115
264 dopamine pathways [photographs, negative], n.d.
51 116
265 integrated tissue specific activity [photographs, negative], n.d.
51 117
266 energy metabolism in the hypothalamus: effects of reproductive hormones [photographs, negative], n.d.
51 118
267 integrated tissue sp. ac. [photographs, negative], n.d.
51 119
268 integrated tissue sp. ac. [photographs, negative], n.d.
51 120
269 integrated tissue sp. ac. [photographs, negative], n.d.
51 121
270 GHB-dehydrogenase [photographs, negative], n.d.
51 122
271 GHB-dehydrogenase [photographs, negative], n.d.
51 123
272 GHB-dehydrogenase [photographs, negative], n.d.
51 124
273 GHB-dehydrogenase [photographs, negative], n.d.
51 125
274 GHB-dehydrogenase [photographs, negative], n.d.
51 126
275 ESN and WFN, Italy (Smith) [negatives], n.d.
51 127
276 columns in striate cortex (monkey) [photographs, negatives], n.d.
51 128
278 computer -- block diagram, n.d.
51 129
279 hypoxic rat injected with black microspheres, n.d.
51 130
280 dopaminerglic systems influence [photographs, negative], n.d.
51 131
281 apomorphine vs. saline on LGU [photographs, negative], n.d.
51 132
282 ocular dominance columns in monkey [photographs, negative], n.d.
51 133
283 effects of slow-wave sleep on LGU [photographs, negative], n.d.
51 134
284 subfornical organ in Battleboro [photographs, negative], n.d.
51 135
285 neural lobe LGU [photographs, negative], n.d.
51 136
286 two compartment model for the behavior of leucine brain -- model V [photographs, negative], n.d.
51 137
287 model VI for behavior of L-leucine in brain [photographs, negative], n.d.
51 138
288 GHB and GABA levels in rat brain [photographs, negative], n.d.
51 139
289 cytosol -- rat [photographs, negative], n.d.
51 140
290 GHB levels -- rat kidney [photographs, negative], n.d.
51 141
291 GHB dehydrogenase activity in rat kidney [photographs, negative], n.d.
51 142
292 GHB -- dehydrogenase activity in rat brain [photographs, negative], n.d.
51 143
293 apomorphine effect on different areas [photographs, negative], n.d.
51 144
294 superior cervical ganglion -- frequency [photographs, negative], n.d.
51 145
295 lump constant theoretical derivations [photographs, negative], n.d.
51 146
296 comparison -- LGU with 3H DG and 14C DG [photographs, negative], n.d.
51 147
298 bar test after morphine [photographs, negative], n.d.
51 148
299 morphine effect on LGU in brain [photographs, negative], n.d.
51 149
300 morphine effect on LGU in brain [photographs, negative], n.d.
51 150
301 fetal sheep [photographs, negative], n.d.
51 151
302 fetal sheep [photographs, negative], n.d.
51 152
303 morphine vs. control tail flick [photographs, negative], n.d.
51 153
304 average rate of GU for entire brain of fetal and newborn sheep, n.d.
51 154
305 chemical analysis of 14C DG and 14C DG-L-P in normal rats [photographs, negative], n.d.
51 155
306 extinction -- Icss [photographs, negative], n.d.
51 156
307 PCO2 and LCGU relationship [photographs, negative], n.d.
51 157
308 habenula afferent and efferent pathways [photographs, negative], n.d.
51 158
309 LGU in laboratory animals [photographs, negative], n.d.
51 159
310 time course of 14C DG and 14C DG-6-P [photographs, negative], n.d.
51 160
311 LGU and arterial PCO2 relationship [photographs, negative], n.d.
51 161
312 habenula and mammillary baby pathways [photographs, negative], n.d.
51 162
313 lateral habenula and mammillary baby pathways [photographs, negative], n.d.
51 163
314 [14C] deoxyglucose autoradiographs of cat brains [photographs, negative], n.d.
51 164
315 effect of acute morphine on GU in rat brain [photographs, negative], n.d.
51 165
315 effect of acute morphine on GU in rat brain [photographs, negative]
51 166
316 fetal sheep [photographs], n.d.
51 167
317 picture procedure, DG method [photographs, negative], n.d.
51 168
318 axotomy in hypoglossal nucleus [photographs, negative], n.d.
51 169
319 axotomy -- tongue functions [photographs, negative], n.d.
51 170
320 age-blood flow and 02 consumption [photographs, negative], n.d.
51 171
321 exchange of methylglucose between plasma and brain tissue [photographs, negative], n.d.
51 172
322 data analysis -- ipsilateral vs. contralateral [photographs, negative], n.d.
51 173
323 LGU stimulation pathway [photographs, negative], n.d.
51 174
324 3H standards calibration curves [photographs, negative], n.d.
51 175
325 visual deprivation protein synthesis [photographs, negative], n.d.
52 1
326 autoradiograph protein synthesis [photographs, negative], n.d.
52 2
327 LGU other connections [photographs, negative], n.d.
52 3
328 LGU: sensory-motor systems [photographs, negative], n.d.
52 4
329 LGU: forebrain terminal areas [photographs, negative], n.d.
52 5
330 electrode placements: contingent and non-contingent [photographs, negative], n.d.
52 6
331 electrode placements: stimulated and non-stimulated [photographs, negative], n.d.
52 7
332 3H methylglucose vs. 14C methylglucose [photographs, negative], n.d.
52 8
333 3H DG vs. 14C DG [photographs, negative], n.d.
52 9
334 morphine bar test and tail flick [photographs, negative], n.d.
52 10
335 [photographs, negative], n.d.
52 11
336 pineal body -- LGU monkey [photographs, negative], n.d.
52 12
337 diazepam -- LGU [photographs, negative], n.d.
52 13
338 TXW vs. control [photographs, negative], n.d.
52 14
339 cretin vs. control [photographs, negative], n.d.
52 15
340 TWX vs. control [photographs, negative], n.d.
52 16
341 physiological parameters -- day vs. night and sleep vs. awake [photographs, negative], n.d.
52 17
342 lesion -- lateral habenula -- LGU [photographs, negative], n.d.
52 18
343 fetal sheep [photographs, negative], n.d.
52 19
344 LGU in lateral habenula [photographs, negative], n.d.
52 20
348 GHB -- anaerobic and aerobic [photographs, negative], n.d.
52 21
349 neural structures regulating fluid balance [photographs, negative], n.d.
52 22
350 GHB dehydrogenase inhibitors on tissue levels of GHB [photographs, negative], n.d.
52 23
351 GHB -- synthesis and degradations pathways [photographs, negative], n.d.
52 24
352 distribution of radioactivity after various stages of fractionation [photographs, negative], n.d.
52 25
353 distribution of brain glycogen among fractions after extraction [photographs, negative], n.d.
52 26
354 brain extraction scheme 1 [photographs, negative], n.d.
52 27
355 brain extraction scheme 2 [photographs, negative], n.d.
52 28
356 histaminergic sites influence on cerebral vessels [photographs, negative], n.d.
52 29
357 neurotransmitter substances -- effect on pial arteriolar diameter [photographs, negative], n.d.
52 30
358 encaphalocoele vs. control, striate cortex of monkey [photographs, negative], n.d.
52 31
359 insulin -- effect on LGU [photographs, negative], n.d.
52 32
360 hyperglycemia vs. normal -- LGU [photographs, negative], n.d.
52 33
361 2-DG-6-PO4 and 2 DG-TLC of brain extracts [photographs, negative], n.d.
52 34
362 LGU in ganglia during stimulation (H2) in urethane anesthesia [photographs, negative], n.d.
52 35
363 probe track [photographs, negative], n.d.
52 36
364 VTA stimulation [photographs, negative], n.d.
52 37
365 VTA stimulation [photographs, negative], n.d.
52 38
366 amphetamine -- LGU [photographs, negative], n.d.
52 39
367 amphetamine -- locomotor and stereotypy scores [photographs, negative], n.d.
52 40
368 amphetamine [photographs, negative], n.d.
52 41
369 amphetamine [photographs, negative], n.d.
52 42
370 amphetamine [photographs, negative], n.d.
52 43
371 angiotensis II and saralasin [photographs, negative], n.d.
52 44
372 angiotensinard saralasin [photographs, negative], n.d.
52 45
373 apomorphine [photographs, negative], n.d.
52 46
374 apomorphine [photographs, negative], n.d.
52 47
375 subfornical organ and septal triangular N. - LGU [photographs, negative], n.d.
52 48
376 subformical organ and septal tricular N. - LGU [photographs, negative], n.d.
52 49
377 sheep LCGU -- pre and postnatal [photographs, negative], n.d.
52 50
378 caffeine -- LGU [photographs, negative], n.d.
52 51
379 caffeine -- LGU [photographs, negative], n.d.
52 52
380 EAS [photographs, negative], n.d.
52 53
381 female rats during cycle [photographs, negative], n.d.
52 54
382 electrical stimulation on pineal gland [photographs, negative], n.d.
52 55
383 female rats during cycle [photographs, negative], n.d.
52 56
384 model I -- leucine traveling BBB [photographs, negative], n.d.
52 57
385 percent change of protein synthesis, glucose utilization and relative twitch [photographs, negative], n.d.
52 58
386 glucose utilization in menstruating rats [photographs, negative], n.d.
52 59
387 postral calcarin fissure [photographs, negative], n.d.
52 60
388 optic radiation tract section [photographs, negative], n.d.
52 61
389 eye occlusion striate cortex [photographs, negative], n.d.
52 62
390 ambient light markings, striate cortex [photographs, negative], n.d.
52 63
391 eye occlusion lateral geniculate [photographs, negative], n.d.
52 64
392 general equ. for measurement of reaction rates with tracers [photographs, negative], n.d.
52 65
394 [125I] HIPDM and metabolic products in blood [photographs, negative], n.d.
52 66
395 molecular structure of HIPDM [photographs, negative], n.d.
52 67
396 [125I] HIPDM single pass extraction [photographs, negative], n.d.
52 68
397 super optical nucleus, salt loading [photographs, negative], n.d.
52 69
398 senescence [photographs, negative], n.d.
52 70
399 maturescence [photographs, negative], n.d.
52 71
400 LGU % change vs. stimulation frequency [photographs, negative], n.d.
52 72
401 sciatic nerve stim. LGU in spinal cord and dorsal root ganglia [photographs, negative], n.d.
52 73
402 water saturated vs. water deprived [photographs, negative], n.d.
52 74
403 water sated vs. H2O deprived [photographs, negative], n.d.
52 75
404 water sated vs. H2O deprived [photographs, negative], n.d.
52 76
405 self-stimulation chapter [photographs, negative], n.d.
52 77
406 self stim. cocaine/d-amphetamine/morphine [photographs, negative], n.d.
52 78
407 criteria for adequate psychophysical threshold determination [photographs, negative], n.d.
52 79
408 self stimulation [photographs, negative], n.d.
52 80
409 self stim. % response vs. ua [photographs, negative], n.d.
52 81
410 self stim. X Z score vs. dose [photographs, negative], n.d.
52 82
411 running speed vs. log pulses per reward [photographs, negative], n.d.
52 83
412 self-stimulation (graphic) [photographs, negative], n.d.
52 84
413 response rate vs. intensity (base line drug) [photographs, negative], n.d.
52 85
414a self stimulation pre/post responses [photographs, negative], n.d.
52 86
414b acute dehydration [photographs, negative], n.d.
52 87
415 acute dehydration [photographs, negative], n.d.
52 88
416 (spinal cord ) acute dehydration [photographs, negative], n.d.
52 89
417 adrenelectomy and dexamethason [photographs, negative], n.d.
52 90
418 nerve stimulation -- dorsal root ganglion [photographs, negative], n.d.
52 91
419 paraventricular nucleus -- acute adrenalectomy [photographs, negative], n.d.
52 92
420 dehydration [photographs, negative], n.d.
52 93
421 plasma and brain, deoxyglucose and deoxyglucose -- phosphate [photographs, negative], n.d.
52 94
422 arterial plasma DG*/G vs. time [photographs, negative], n.d.
52 95
423 pituitary neural lobe, water sated/water deprived [photographs, negative], n.d.
52 96
424 septal triangular nucleus [negative], n.d.
52 97
425 subfornical organ [photographs, negative], n.d.
52 98
426 latero-lateral habenula [photographs, negative], n.d.
52 99
427 spinal cord sciatic nerve stimulation [photographs, negative], n.d.
52 100
428 plasma concentration (arterial and venous) vs. time [photographs, negative], n.d.
52 101
429 pathways of glucose metabolism [photographs, negative], n.d.
52 102
430 uptake of [32P] glucose-6-phosphate [photographs, negative], n.d.
52 103
431 loss of label rates of [2-3H] glucose and [U14C] glucose in brain [photographs, negative], n.d.
52 104
432 electrical stim. of sciatic nerve on LGU in spinal cord [photographs, negative], n.d.
52 105
433 fractions of total tissue 14c content in form of free [14c] deoxyglucose in brain [photographs, negative], n.d.
52 106
434 time courses of [14c] DG and 14c DG-6-P, n.d.
52 107
435 measured and theoretical time courses of [14c] DG-6-P in brain [photographs, negative], n.d.
52 108
436 arteriovenous differences of [14c] glucose and [14c] DG [photographs, negative], n.d.
52 109
437 newborn lamb [photographs, negative], n.d.
52 110
438 comparative rates of loss of label from 2-[3H] glucose and, n.d.
52 111
439 nonacidic compounds w/vicinal cis diol. Groups [photographs, negative], n.d.
52 112
442 effects of fasting on tissue levels of GHB [photographs, negative], n.d.
52 113
443 biosynthesis of GHB by intact mitochondria [photographs, negative], n.d.
52 114
444 rates of glucose utilization in rat cervical ganglion [photographs, negative], n.d.
52 115
445 representative values for LCGU in conscious albino rat and monkey, n.d.
52 116
446 [photographs, negative], n.d.
52 117
447 cretin vs. control [photographs, negative], n.d.
52 118
448 parasaggittal blindspot [photographs, negative], n.d.
52 119
449 cretin vs. control [photographs, negative], n.d.
52 120
450 cretin vs. control [photographs, negative], n.d.
52 121
451 refused monkey cortical section [photographs, negative], n.d.
52 122
454 E-cat scan of normal brain after injection of [18-F] fluorodeoxyglucose[photographs, negative], n.d.
52 123
455 [photographs, negative], n.d.
52 124
456 3H/14C ration in blood glucose [photographs, negative], n.d.
52 125
457 pathways of GHB metabolism [photographs, negative], n.d.
52 126
458 LGU in cervical ganglion [photographs, negative], n.d.
52 127
459 [photographs, negative], n.d.
52 128
460 simulation effects of frequency on LGU [photographs, negative], n.d.
52 129
461 effects of acute dehydration on LBG in subfornical organ [photographs, negative], n.d.
52 130
462 effects of acute dehydration on LGU in paracentricular nucleus [photographs, negative], n.d.
52 131
463 effects of DD AVP on LGU of septaltriangular nucleus [photographs, negative], n.d.
52 132
464 effects of DD AVP on LGU of lateral habenula nucleus, subfornical organ and paracentricular nucleus [photographs, negative], n.d.
52 133
465 Krebs cycle [photographs, negative], n.d.
52 134
466 Krebs cycles [photographs, negative], n.d.
52 135
467 metabolism of carbohydrates [photographs, negative], n.d.
52 136
468 metabolism of carbohydrate w/2-DG and 2-DG-6-P [photographs, negative], n.d.
52 137
469 [photograph], n.d.
52 138
470 G-6-P derivative of glucose fraction separated by chromatography [photographs, negative], n.d.
52 139
471 separation of glucose by column and paper chromatography [photographs, negative], n.d.
52 140
472 MPTP and L-DOPA [photographs, negative], n.d.
52 141
473 MPTP and L-DOPA [photographs, negative], n.d.
52 142
474 Estrus cycle [photographs, negative], n.d.
52 143
475 dose dependent of methylphoedine [photographs, negative], n.d.
52 144
476 DPTP and L-DOPA [photographs, negative], n.d.
52 145
477 G-6-P and DG-6-P activities in rat tissues [photographs, negative], n.d.
52 146
478 LGU in iodomethacin and dexamethasone [photographs, negative], n.d.
52 147
479 radiochemical heterogeneity of eluate in Dowex-1-borate column [photographs, negative], n.d.
52 148
480 theoretical time courses of [14c] DG-6-P in brain [photographs, negative], n.d.
52 149
481 glucose-6-[32p] phosphate arterial and cerebral venous concentrations [photographs, negative], n.d.
52 150
482 [14c] G-6-P single pass extraction fraction, n.d.
52 151
484 time courses of [14C] DG and [14C] DG-6-P [photographs, negative], n.d.
52 152
485 effects of antidromic stimulation on the rates of glucose utilization [photographs, negative], n.d.
53 1
486 plasma concentration vs. rate constants [photographs, negative], n.d.
53 2
487 difference in glucose utilization vs. frequency of stimulation (Hz) [photographs, negative], n.d.
53 3
488 plasma glucose concentration vs. glucose infusion rate [photographs, negative], n.d.
53 4
489 lumped constant at different plasma glucose levels [photographs, negative], n.d.
53 5
490 arterial and venous concentrations [photographs, negative], n.d.
53 6
491 self stimulation [photographs, negative], n.d.
53 7
492 self stimulation II [photographs, negative], n.d.
53 8
493 LGN in intact binocular vision vs. chronic monocular deprivation [photographs, negative], n.d.
53 9
494 dorsal root ganglion [photographs, negative], n.d.
53 10
495 monkey arm movement [photographs], n.d.
53 11
496 estimation of rate constants for dephosphorylation [photographs, negative], n.d.
53 12
497 LCGU in globus pallidus and subthalmic nucleus [photographs, negative], n.d.
53 13
498 DG6P by NMR vs. DG6P [GC-MS] [photographs, negative], n.d.
53 14
499 LCGU in sensorimotor cortex and ventromedial thalamus [photographs, negative], n.d.
53 15
500 LCGU [photographs, negative], n.d.
53 16
501 % change in G.U. from no stimulation control values [photographs, negative], n.d.
53 17
502 % change in G.U. from no stimulation control values [photographs, negative], n.d.
53 18
503 % change in GU (IPSI vs. contralateral) [photographs, negative], n.d.
53 19
504 LCGU in medial prefrontal and anterior cingulated cortex [photographs, negative], n.d.
53 20
505 % change in GU, anterior cingulated and dorsomedial caudate [photographs, negative], n.d.
53 21
506 changes in metabolic activity during self-stimulation [photographs, negative], n.d.
53 22
507 behaviors associated w/self-stimulation to the ventral mid brain [photographs, negative], n.d.
53 23
508 concentrations of glucose, glycogen and lactate [photographs, negative], n.d.
53 24
509 [14c] DG concentration in plasma, gray and white [photographs, negative], n.d.
53 25
510 % of 14c as 14c-DG/amount of 14c-DGP found after single injection [photographs, negative], n.d.
53 26
511 principle of the assay of glucose-6-P in vivo by selective detritiation of [2-3H]G [photographs, negative], n.d.
53 27
512 incorporation of 2-[14c] deoxyglucose into glycogen a [photographs, negative], n.d.
53 28
513 GU in control post-radiation: 4 days and 4 weeks [photographs, slides], n.d.
53 29
514 glucose infusion rate[photographs, negative], n.d.
53 30
515 lumped constant vs. arterial plasma glucose [photographs, negative], n.d.
53 31
516 arterial plasma glucose concentration vs. duration of infusion [photographs, negative], n.d.
53 32
517 determination of lumped constants during hyperglycemia state [photographs, negative], n.d.
53 33
518 arterial plasma glucose concentration vs. rate constants in grey and white matter [photographs, negative], n.d.
53 34
519 lumped constant vs. arterial plasma glucose concentration [photographs, negative], n.d.
53 35
520 lack of uptake of [32p] G-6-P [photographs, negative], n.d.
53 36
521 Hawkins brain, DG-6-P graphs [photographs, negative], n.d.
53 37
522 stimulation of sciatic nerve [photographs, negative], n.d.
53 38
523 cytochemical localization of G-6-P [photographs, negative], n.d.
53 39
524 localization of G6-pase in a nerve cell [photographs, negative], n.d.
53 40
525 effects of catecholamines of cerebral circulation and metabolism [photographs, negative], n.d.
53 41
526 eye occlusion striate cortex [photographs, negative], n.d.
53 42
527 control, Tx and Tx + warm [photographs, negative], n.d.
53 43
528 effects of amphetamines on brain glucose metabolism D [photographs, negative], n.d.
53 44
530 Ci*/cp* vs. real time (square wave experiment) [photographs, negative], n.d.
53 45
531 influence of duration of experimental period on weighted ave G.U. [photographs, negative], n.d.
53 46
532 Ci*/Cp* vs. stretch time [photographs, negative], n.d.
53 47
533 Ci*/Cp* vs. real time [photographs, negative], n.d.
53 48
534 operational equation with 5 rate constants [photographs, negative], n.d.
53 49
535 LCGU vs. methylphenidate [photographs, negative], n.d.
53 50
536 methlyphenidate [photographs, negative], n.d.
53 51
537 LCGU vs. methylphenidate [photographs, negative], n.d.
53 52
538 the localization of G-6-pase in nerve cell of cerebral cortex [photographs, negative], n.d.
53 53
540 G-6-P localization in liver [photographs, negative], n.d.
53 54
541 effects of L-DOPA treatment on LCGU [photographs, negative], n.d.
53 55
542 L-DOPA effects on LCGU in normal and MPTP-treated monkeys [photographs, negative], n.d.
53 56
543 % dephosphorylation vs. % dephosphorylation of DG-6-P [photographs, negative], n.d.
53 57
544 stretch time vs. apparent distribution space in sensorimotor cortex [photographs, negative], n.d.
53 58
545 weighted average tissue concentration [photographs, negative], n.d.
53 59
546 Ci*(T)/Cp*(T) vs. stretch time in sensory cortex [photographs, negative], n.d.
53 60
547 Ci*(T)/Cp*(T) vs. stretch time in hypothalamus [photographs, negative], n.d.
53 61
548 substantia nigra (pars reticulate) [photographs, negative], n.d.
53 62
549 N20 VOI % vs. min. of inhalation [photographs, negative], n.d.
53 63
550 apparent distributions space vs. real time [photographs, negative], n.d.
53 64
551 Ci*(T)/Cp* vs. real time (square wave experiments) [photographs, negative], n.d.
53 65
552 body temp. vs. time (min. after injection) [photographs, negative], n.d.
53 66
553 N moles GHB/g brain vs. dose of GHB (mg/kg) [photographs, negative], n.d.
53 67
554 t (C at 0-60 min.) vs. dose of GHB (mg/kg) [photographs, negative], n.d.
53 68
555 cerebral and cerebellar cortex [photographs, negative], n.d.
53 69
556 white matter structures [photographs, negative], n.d.
53 70
557 % error of prediction: s. colliculus, pontine gray matter and sunstantia nigra [photographs, negative], n.d.
53 71
558 deep cerebral gray structures [photographs, negative], n.d.
53 72
559 effect of L-gulonate or D-glucuronate in plasma disappearance curve (GHB) [photographs, negative], n.d.
53 73
560 weighted LCGU vs. time conc. rem sleep [photographs, negative], n.d.
53 74
561 % error of prediction [photographs, negative], n.d.
53 75
562 rate constants [photographs, negative], n.d.
53 76
563 model and equa. for estimation of rate constants for dephosphorylation [photographs, negative], n.d.
53 77
565 weighted average tissue concentration [photographs, negative], n.d.
53 78
566 pontine gray [photographs, negative], n.d.
53 79
567 globus pallidus [photographs, negative], n.d.
53 80
568 cerebellar cortex [photographs, negative], n.d.
53 81
569 corpus callosum [photographs, negative], n.d.
53 82
570 arterial plasma concentration [photographs, negative], n.d.
53 83
571 arterial plasma concentration [photographs, negative], n.d.
53 84
572 sensory cortex [photographs, negative], n.d.
53 85
573 influence of duration of experimental period on weighted ave. G.U. [photographs, negative], n.d.
53 86
574 total DG-6-P concentration, n.d.
53 87
575 concentration -- weighted fraction of total time spent in rem sleep [photographs, negative], n.d.
53 88
576 [14c] DG concentration vs. time [photographs, negative], n.d.
53 89
577 relative 3H/14c (sample/injectant) [photographs, negative], n.d.
53 90
578 labeled compounds remaining after hexokinase purification step [photographs, negative], n.d.
53 91
579 pyrrolidone-5-carboxylate is a major contaminant of huang and veech ‘glucose' [photographs, negative], n.d.
53 92
580 % total DPM and relative 3H/14C ratio [photographs, negative], n.d.
53 93
581 labeled contaminants in huang and veech ‘glucose' [photographs, negative], n.d.
53 94
582 lability of [2-3H, U-14C] glucose during purification, n.d.
53 95
583 labeled compounds remaining after glucose oxidase purification step [photographs, negative], n.d.
53 96
584 glucose purification [photographs, negative], n.d.
53 97
585, n.d.
53 98
586 LCGU in rem sleep [photographs, negative], n.d.
53 99
587 LCGU vs. time concentration slow wave sleep [photographs, negative], n.d.
53 100
588 washout correction experiment [photographs, negative], n.d.
53 101
589 ulisse [photographs, negative], n.d.
53 102
590 ulisse [photographs, negative], n.d.
53 103
591 ulisse [photographs, negative], n.d.
53 104
592 ulisse [photographs, negative], n.d.
53 105
593 pet scan -- Italian [photographs, negative], n.d.
53 106
594 cerebellar cortex [photographs, negative], n.d.
53 107
595 internal capsule [photographs, negative], n.d.
53 108
596 tissue 2DG and 2DG-6-P, n.d.
53 109
597 relationship between cerebral oxygen consumption and G.U. [photographs, negative], n.d.
53 110
598 body temp. vs. time [photographs, negative], n.d.
53 111
599 lumped constant in several species [photographs, negative], n.d.
53 112
600 rate constants for 3-0-methylglucose [photographs, negative], n.d.
53 113
601 ratio of antibody to cytosol or to homogenate [photographs, negative], n.d.
53 114
602 rate constants for dephosphorylation [photographs, negative], n.d.
53 115
603 blood flow vs. age [photographs, negative], n.d.
53 116
604 patlak plot [photographs, negative], n.d.
53 117
605 equa. for estimation of rate constants for dephosphorylation [photographs, negative], n.d.
53 118
606 GH B in cytosol [photographs, negative], n.d.
53 119
607 GHB dehydrogenase vs. sod. valproate [photographs, negative], n.d.
53 120
608 brain growth in different species in relation to birth [photographs, negative], n.d.
53 121
609 parkisonian syndrome [photographs, negative], n.d.
53 122
610 [14C] DG and [14C] DG-6-P concentration vs. time [photographs, negative], n.d.
53 123
612 theoretical calculation of [14C] DG-6- P [photographs, negative], n.d.
53 124
613 2 DG and rem sleep [photographs, negative], n.d.
53 125
614 GHB activity vs. time [photographs, negative], n.d.
53 126
615 time course of average brain DG-6-P concentration [photographs, negative], n.d.
53 127
616 DG-6-P glucose clamp [photographs, negative], n.d.
53 128
617 futile cycle associated w/ G6P (G6 pase) [photographs, negative], n.d.
53 129
618 Huang and Beech TLC contaminants [photographs, negative], n.d.
53 130
619 L-DG and enzyme [photographs, negative], n.d.
53 131
620 SSA formed vs. pH [photographs, negative], n.d.
53 132
621 SSA and [symbol] - KG [photographs, negative], n.d.
53 133
622 [symbol] - KG, GHB and enzyme [photographs, negative], n.d.
53 134
623 plasma glucose in normoglycemia [photographs, negative], n.d.
53 135
625 plasma glucose in hyperglycemia [photographs, negative], n.d.
53 136
626 pulse and square wave in S. N. [photographs, negative], n.d.
53 137
627 pulse and sq. wave in sensory cortex [photographs, negative], n.d.
53 138
628 pulse and sq. wave in dorsal thalamus [photographs, negative], n.d.
53 139
629 pulse and sq. wave in whole brain [photographs, negative], n.d.
53 140
630 pulse and sq. wave in cerebellar cortex [photographs, negative], n.d.
53 141
631 pulse and sq. wave in hypothalamus [photographs, negative], n.d.
53 142
632 pulse and sq. wave in internal capsule [photographs, negative], n.d.
53 143
633 L-hydroxyglutaric acid TMS [photographs, negative], n.d.
53 144
634 V-hydroxybutyric acid vs. temp. [photographs, negative], n.d.
53 145
635 veech contaminants [photographs, negative], n.d.
53 146
636 pontine gray (Pulse and SQ. Wave) [photographs, negative], n.d.
53 147
637 plasma glucose in hypoglycemia [photographs, negative], n.d.
53 148
638 veech column separation [photographs, negative], n.d.
53 149
639 glucose utilization in sq. wave [photographs, negative], n.d.
53 150
640 duration of experimental period on weighted G.U. (pulse) [photographs, negative], n.d.
53 151
641 after derivatization of glucose w/ hexokinase and G. oxidase [photographs, negative], n.d.
53 152
642 veech analysis of contaminants [photographs, negative], n.d.
53 153
643 brain extract -- dowex (Veech) [photographs, negative], n.d.
53 154
644 veech contaminants after separation [photographs, negative], n.d.
53 155
645 plasma glucose vs. pulse and sq. wave [photographs, negative], n.d.
53 156
646 rate constants vs. length of experiment [photographs, negative], n.d.
53 157
647 CBF in normal mouse [photographs, negative], n.d.
53 158
648 plasma glucose concentration in normoglycemia[photographs, negative], n.d.
53 159
649 plasma glucose concentration in hypoglycemia [photographs, negative], n.d.
53 160
650 plasma glucose concentration in hyperglycemia, n.d.
54 1
651 cocaine / activity [photographs, negative], n.d.
54 2
652 cocaine -- gluc. Util. vs. activity [photographs, negative], n.d.
54 3
653 acute MPTP : olive [photographs, negative], n.d.
54 4
654 MPTP acute : nigra [photographs, negative], n.d.
54 5
655 mouse blood flow [photographs, negative], n.d.
54 6
656 arithmetic average rate constants [photographs, negative], n.d.
54 7
657 hypothalamus [photographs, negative], n.d.
54 8
658 substantia nigra reticulata [photographs, negative], n.d.
54 9
659 rate constants determined for cerebellar cortex [photographs, negative], n.d.
54 10
660 rate constants -- SN ret. [photographs, negative], n.d.
54 11
661 constants -- internal capsule [photographs, negative], n.d.
54 12
662 rate constants -- hypothalamus [photographs, negative], n.d.
54 13
663 arithmetic average rate constants for white matter [photographs, negative], n.d.
54 14
664 mouse blood flow rate corrections [photographs, negative], n.d.
54 15
665 LCBF VS. LCGU in normal mice [photographs, negative], n.d.
54 16
666 LCBF VS. LCGU in normal mice [photographs, negative], n.d.
54 17
667 cocaine -- activity vs. time after 2 DG. [photographs, negative], n.d.
54 18
668 rate constants -- composite [photographs, negative], n.d.
54 19
669 metabolites -- dowex -- 1 -- formate column [photographs, negative], n.d.
54 20
670 methyl glucose plasma concentration vs. time [photographs, negative], n.d.
54 21
671 elution of methylglucose [14C] vs. [U -- 14C ] [photographs, negative], n.d.
54 22
672 hexokinase on dowex -- 1 -- formate effluent [photographs, negative], n.d.
54 23
673 plasma glucose on dowex in normoglycemia and hyperglycemia [photographs, negative], n.d.
54 24
674 cocaine LCGU vs. dose [photographs, negative], n.d.
54 25
675 drugs and LCGU [photographs, negative], n.d.
54 26
676 cocaine -- LCGU in nucl. acc. and SN.[photographs, negative], n.d.
54 27
677 neurotransmitters and basal ganglia [photographs, negative], n.d.
54 28
678 main connections of the nigrostriatal system [photographs, negative], n.d.
54 29
679 diagram of basal ganglia [photographs, negative], n.d.
54 30
680 [photographs, negative], n.d.
54 31
682 hypergly. methyl glucose [photographs, negative], n.d.
54 32
683 extractions of sugars [photographs, negative], n.d.
54 33
684 % of 14C applied to dowex -- 1 -- formate column [photographs, negative], n.d.
54 34
685 extraction of metabolites [photographs, negative], n.d.
54 35
686 diagram of precursor pool [photographs, negative], n.d.
54 36
687 10K model [photographs, negative], n.d.
54 37
688 plasma glucose in hyperglycemia [photographs, negative], n.d.
54 38
689 plasma glucose in normoglycemia [photographs, negative], n.d.
54 39
690 plasma glucose in hypoglycemia [photographs, negative], n.d.
54 40
691 5 rate constants model [photographs, negative], n.d.
54 41
692 fractional rate of product loss [photographs, negative], n.d.
54 42
693 LCGU vs. med. geniculate [photographs, negative], n.d.
54 43
694 triopental and celiac ganglionectomy [photographs, negative], n.d.
54 44
695 Gl. util. thiopental and celiac ganglionectomy [photographs, negative], n.d.
54 45
696 G.U. thiopental and celiac ganglionectomy [photographs, negative], n.d.
54 46
697 G.U. thiopental and celiac ganglionectomy [photographs, negative], n.d.
54 47
698 lumped constants in normo and hypo glycemia [photographs, negative], n.d.
54 48
699 lumped constants in normo, hypo and hyper glycemia [photographs, negative], n.d.
54 49
700 lumped constants in arterial and venous concentration [photographs, negative], n.d.
54 50
701 methylglucose sections [photographs, negative], n.d.
54 51
702 statistical analysis, experiments w/ sq. wave [photographs, negative], n.d.
54 52
703 rate constants used in calculation of LCGU [photographs, negative], n.d.
54 53
704 statistical analysis experiments w/ pulse input [photographs, negative], n.d.
54 54
705 arterial plasma concentration in exp. animals [photographs, negative], n.d.
54 55
706 LCGU 3K and 4K models [photographs, negative], n.d.
54 56
707 rate constants -- sq. wave and pulse [photographs, negative], n.d.
54 57
708 methylglucose sections [photographs, negative], n.d.
54 58
709 lumped constants w/ sq. wave [photographs, negative], n.d.
54 59
710 plasma glucose on dowex -- normo, hypo and hyper glycemia [photographs, negative], n.d.
54 60
711 extraction of metabolites [photographs, negative], n.d.
54 61
712 recovered DPM [photographs, negative], n.d.
54 62
713 recovery of sugars from dowex [photographs, negative], n.d.
54 63
714 correction (Veech) for blood remaining in brain [photographs, negative], n.d.
54 64
715 r vs. brain glucose concentration [photographs, negative], n.d.
54 65
716 hexose distribution ratios vs. brain glucose level [photographs, negative], n.d.
54 66
717 hexose distribution ratios vs. plasma levels [photographs, negative], n.d.
54 67
718 non -- acidic, non -- phosph. metabolites [photographs, negative], n.d.
54 68
719 labeled Non -- acidic and non -- phosphor. metabolites [photographs, negative], n.d.
54 69
720 phosphorylation coefficient vs. plasma concentration [photographs, negative], n.d.
54 70
721 elodea cell summary [photographs, negative], n.d.
54 71
722 methylglucose sections [photographs, negative], n.d.
54 72
723 elodea cells [photographs, negative], n.d.
54 73
724 methylglucose mouse [photographs, negative], n.d.
54 74
725 methylglucose distribution ratio [photographs, negative], n.d.
54 75
726 steady -- state methylgl. distribution ratio [photographs, negative], n.d.
54 76
727 total tissue radioactivity [photographs, negative], n.d.
54 77
728 rate constants estimated from DG and DG-6-P concentration [photographs, negative], n.d.
54 78
729 rate constants estimated from total tissue radioactivity [photographs, negative], n.d.
54 79
730 heterogeneous tissue [photographs, negative], n.d.
54 80
731 rate constant for phosphorylation [photographs, negative], n.d.
54 81
732 4K rate constants gray matter [photographs, negative], n.d.
54 82
734 equilibrium MG tissue/ plasma [photographs, negative], n.d.
54 83
735 time course of DG metabolites [photographs, negative], n.d.
54 84
736 r vs. Ce [photographs, negative], n.d.
54 85
737 lumped constant [photographs, negative], n.d.
54 86
738 brain glucose util. in hyperglycemia [photographs, negative], n.d.
54 87
739 monkey vs. cortex [photographs, negative], n.d.
54 88
740 rate constants for various levels of hyperglycemia [photographs, negative], n.d.
54 89
741 influence of rate constants on integrated pool S.P. [photographs, negative], n.d.
54 90
744 lumped constant at various levels of hyperglycemia [photographs, negative], n.d.
54 91
745 effects of hyperinsulinemia [photograph, negative], n.d.
54 92
748 GHB and temp. vs. time [photographs, negative], n.d.
54 93
757 [symbol] including equation [photograph], n.d.
54 94
760 diagram of freely moving rat [photographs, negative], n.d.
54 95
765 LCGU in sup. collic., cerebellar cortex, med. gen. and int. cap. [negative], n.d.
54 96
766 LCGU in sup. collic. hypothalamus, int. cap. And rate constants [photographs, negative], n.d.
54 97
777 autoradiographic film test [photographs, negative], n.d.
54 98
779 L-thyroxine uptake by brain [photographs, negative], n.d.
54 99
795 pictorial diagram, protein synth. [photograph], n.d.
54 100
799 distribution of CO2 in cells [negative], n.d.
54 101
800 CO2 fixation in cell cultures [photographs], n.d.
54 102
801 DNA/ stairs -- joke [photographs, negative], n.d.
54 103
811 equation for deoxyglucose methods [photograph], n.d.
54 104
812 functional anatomy of 2 DG equ. [photographs, negative], n.d.
54 105
813 tower of matches -- Joke [photographs, negative], n.d.
54 106
814 nut and bolt -- joke [photographs, negative], n.d.
54 107
816 equation for Patlak plot [photograph], n.d.
54 108
817 rates of hexoses transport [photograph], n.d.
54 109
818 time courses uptake [photograph], n.d.
54 110
819 equilibrium of CH3-glucose tissue [photograph], n.d.
54 111
820 Michaelis-Menten kinetics [photograph], n.d.
54 112
821 reaction catalyzed by pyruvate carboxylate [photograph], n.d.
54 113
823 DG-G-P concentration in tissue reflects true average of rates of phosphorylation [photograph], n.d.
54 114
824 total mixed tissue of two compartments [photograph], n.d.
54 115
825 effect of glutamine conc. In culture medium [photograph], n.d.
54 116
826 effect of varying the timing of medium change [photograph], n.d.
54 117
827 role of individual medium constituents [photograph], n.d.
54 118
828 glutamine is source of glutamate in culture medium [photograph], n.d.
54 119
829 destruction of cultures with a brief pulse of medium [photograph], n.d.
54 120
830 destruction of cultures during medium change (buffer) [photograph], n.d.
54 121
831 destruction of cell cultures: protection by NMDA [photograph], n.d.
54 122
832 3-H dopamine uptake vs. concentration of antagonists [photograph], n.d.
54 123
833 brief exposure to fresh medium (pulse) [photograph], n.d.
54 124
834 dual pathway for the oxidation of [symbol]-hydrobutyrate [photograph], n.d.
54 125
835 tech notes: whole-body autoradiographs of mouse for G-6-p-ase activities [photograph], n.d.
54 126
836 release of dopamine by added ligands [photograph], n.d.
54 127
837 effects of antagonists on resistance [photograph], n.d.
54 128
838 percentage uptake of 3-H dopamine vs. concentration of agonists [photograph], n.d.
54 129
839 effect of glutamine concentration In culture medium [photograph], n.d.
54 130
840 release of 3-H dopamine from pre-labelled cultures [photograph], n.d.
54 131
841 reaction catalyzed by the mitochondrial hydroxyacid oxoacid transhydrogenase [photograph], n.d.
54 132
842 neurotransmitters production cycle [photograph], n.d.
54 133
843 model of DG method including G-6 p-ase activity [photograph], n.d.
54 134
844 lumped constant vs. arterial plasma glucose conc. [photograph], n.d.
54 135
845 DG model including G-6-p-ase activity [photograph], n.d.
54 136
846 DG model including G-6-p-ase activity, n.d.
54 137
848 relationships among arterial plasma and brain G. concentration and CMRglc [photograph], n.d.
54 138
849 apparent dist. Space (whole brain, pont. Gray, cerebral cortex) [photograph], n.d.
54 139
850 apparent dist. Space (sub. nigra, sens. cortex, int. capsule [photographs, negative], n.d.
54 140-146
851-857 scientific couns. [not photo], n.d.
54 147
871 rt. hypoglossal nucleus and rt. nucleus tractus solitarius [photographs], n.d.
54 148
872 MPTP—treated and normal [photographs], n.d.
54 149
873 human -- eyes open and closed [photographs], n.d.
54 150
875 DG in working monkey spinal cord [photographs], n.d.
54 151
887 LCGU spinal cord (monkey) [photographs], n.d.
54 152
889 LCGU spinal cord [photographs], n.d.
54 153
910 MPTP lab. of cerebral metabolism [photographs], n.d.
54 154
943 monkey using left arm -- Cerebellum [photographs], n.d.
54 155
944 monkey using left arm [photographs], n.d.
54 156
945 paraventricular nucleus [photographs], n.d.
54 157
946 superior cervical ganglia [photographs], n.d.
54 158
947 whisker barrel [photographs], n.d.
54 159
947 whisker barrel CBF paper [photographs, negative], n.d.
54 160
948 methyl glucose in brain [photographs], n.d.
54 161
949 monkey using left arm -- Parietal [photographs], n.d.
54 162
958 pituitary [photographs], n.d.
54 163
963 monkey using left arm [photographs], n.d.
54 164
964 striate cortex [photographs], n.d.
54 165
1001 postnatal change in cerebral blood flow, n.d.
54 166
1002 phoenoxybenzamine [photograph], n.d.
54 167
1012 monkey striate cortex (awake vs. sleep) [photographs], n.d.
54 168
1013 hypoglossal nucleus and tractus solitarius [photographs], n.d.
54 169
1014 adrenalectomy and dexamethasone [photographs], n.d.
54 170
1062 monkey ocular dominance columns [photographs], n.d.
54 171
1126 Joseph Barcroft on oxygen, n.d.
54 172
1126 quote: oxygen required for work, n.d.
54 173
1127 methylglucose equilibrium tissue, n.d.
54 174
1127 pet diagram, n.d.
54 175
1128 "rate constants" for efflux of DG/phosphorylation, n.d.
54 176
1129 behavior of DG in heterogeneous tissue, n.d.
54 177
1130 equation for rate of GU, n.d.
54 178
1131 behavior of DG in heterogeneous tissue, n.d.
54 179
1132 heterogeneous model (no loss), n.d.
54 180
1133 behavior of DG in heterogeneous tissue (no loss), n.d.
54 181
1134 DG method assumptions, n.d.
54 182
1135 Y CMR glc. vs. time, n.d.
54 183
1136 K4 to K3 in simulated mixed tissue, n.d.
54 184
1137 tissue concentration of DG, DG-6-P and radioactivity estimate with hetero tissue model, n.d.
54 185
1138 homogeneous tissue: estimated DG, DG-6-P conc., n.d.
54 186
1139 DG, DG-6-P and radioactivity concentration For simulated heterogeneous tissue, n.d.
54 187
1140 behavior of DG in heterogeneous tissue, n.d.
54 188
1141 behavior of DG in homogeneous tissue and loss (4K), n.d.
54 189
1142 behavior of DG in homogeneous tissue - 3K, n.d.
54 190
1143 design for experimental determining of glucose utilization rate, n.d.
54 191
1144 equation for rate of glucose utilization, n.d.
54 192
1145 heterogeneous vs. homogeneous - CMR, n.d.
54 193
1146 heterogeneity model for DG in tissue, n.d.
54 194
1147 equation for rate of G.U. (no loss), n.d.
54 195
1148 emperor's clothes - quote, n.d.
54 196
1149 truth / stumble - quote, n.d.
54 197
1150 rate constants for various arterial plasma, n.d.
54 198
1151 model of DG method including G-6-P-ase, n.d.
54 199
1161 methyl glucose dist. ratio [photographs, negative], n.d.
54 200
1178 astroglial metabolism, n.d.
54 201
1179 astroglial metabolism plus potassium, n.d.
54 202
1180 monkey cortical area [photographs, negative], n.d.
54 203
1181 MRI + PET in human [photographs], n.d.
54 204
1185 diagram of AV exchange [photographs, negative], n.d.
54 205
1186, n.d.
54 206
1187 on the regulation of the blood supply of the brain, n.d.
54 207
1189 amino acid incorporation, n.d.
54 208
1190 regional [symbol] protein synthesis, n.d.
54 209
1191 Vmax / Km for NADPH, n.d.
54 210
1192 NADPH production, n.d.
54 211
1193 kinetic constants for inhibition of GHB-dehydrogenase, n.d.
54 212
1194 rate of transhydrogenase reaction, n.d.
54 213
1195 stoichiometry of [symbol]-HB, n.d.
54 214
1198A steady state ratios of [3H] in tissue pools to plasma, n.d.
54 215
1200A time courses of plasma, n.d.
54 216
1201A schematic of the definition of [symbol], n.d.
54 217
1202 regional values of [symbol] in adult males, n.d.
54 218
1203A effects of unilateral electrical stimulation, n.d.
54 219
1204A effects of lt. thiopental anesthesia, n.d.
54 220
1205A time course of plasma, n.d.
54 221
1206A denominator of the operational equation, n.d.
54 222
1207 values of [symbol] and rates of protein in adult male rat, n.d.
54 223
1208 rate of leucine into protein, n.d.
54 224
1209 equation of the L-[1-14C] leucine method, n.d.
54 225
1210 higher brain functions in humans, n.d.
54 226
1210A, n.d.
54 227
1211 functional state on protein synthesis, n.d.
54 228
1212 effects of aging on rates, n.d.
54 229
1213 values of [symbol] WB in the rat, n.d.
54 230
1214 effects of unilateral hypoglossal axotomy, n.d.
54 231
1215 [psi] v. [symbol] in the whole brain, n.d.
54 232
1216 L-[1-14C] leucine method, n.d.
54 233
1217 constant C*p for a long experimental interval, n.d.
54 234
1220 quote from W. Thomson, n.d.
54 235
1221 substances affecting phosphofructokinase activity, n.d.
54 236
1222 operational equation of the L-[1-14C] leucine method, n.d.
54 237
1224 biochemical reaction in vivo, n.d.
54 238
1225 human myelin basic proteins, n.d.
54 239
1231, n.d.
54 240
1232 cerebral blood flow (chat) [photographs, negative], n.d.
54 241
1233 CBF vs. aging [photographs, negatives], n.d.
54 242
1234 rCMRglc. vs. tme [photographs, negative], n.d.
54 243
1235 rate constant vs. end time of last scan [photographs, negative], n.d.
54 244
1236 K vs. end time of last scan [photographs], n.d.
55 1
1237 rCMRglc. vs. time [photographs, negative], n.d.
55 2
1238 gluc. util. vs. midscan time [photographs, negative], n.d.
55 3
1239 glucose vs. fructose as phosphate donor [photographs, negative], n.d.
55 4
1240 distribution of 14C in arterial metabolites [photographs, negative], n.d.
55 5
1242 DG of metabolites levels vs. time of the pulse [photographs, negative], n.d.
55 6
1243 DPM before and after acid hydrolysis [photographs, negative], n.d.
55 7
1244 influence of 14C metabolites on G.U. in brain [photographs, negative], n.d.
55 8
1245 steady state brain -- plasma distribution ratios [photographs, negative], n.d.
55 9
1247 elution gradient, standards, ethanol extract [photographs, negative], n.d.
55 10
1249 concentration of DG-6-P in incubation vs. G-1, 6-P-2 concentration [photographs, negative], n.d.
55 11
1250 lumped constant -- DG vs. brain glucose content [photographs, negative], n.d.
55 12
1251 gradient elution and ethanol extract, n.d.
55 13
1252 metabolite concentration vs. incubation time [photographs, negative], n.d.
55 14
1253 14C --labeled metabolites in ethanol extract [photographs, negative], n.d.
55 15
1254 concentration of 14C compounds vs. time after DG pulse [photographs, negative], n.d.
55 16
1256 Huxley quote on mathematics, n.d.
55 17
1257 profile of acetate elution gradient [photographs, negative], n.d.
55 18
1259 thiopental anesthesia, n.d.
55 19
1260 rates of protein synthesis in adult male rat, n.d.
55 20
1261 L-valine flooding - protein synthesis, acid soluble pools, n.d.
55 21
1262 L-valine flooding - bound a.a. pools, n.d.
55 22
1263 definition of [symbol], n.d.
55 23
1264 value of [symbol] in hypoglossal axotomy, n.d.
55 24
1265 determination of [symbol], n.d.
55 25
1266 simple operational equation protein synthesis, n.d.
55 26
1267 operational equation and definitions - protein synthesis, n.d.
55 27
1268 denominator of operational equation, n.d.
55 28
1269 electrical stimulation of sciatic nerve on protein synthesis in spinal cord and DRG, n.d.
55 29
1270 values of [symbol] in developing rat, n.d.
55 30
1271 definition of [symbol] in steady state, n.d.
55 31
1272 flow sheet diagram for protein synthesis experiments, n.d.
55 32
1273 leucine in tissue pool vs. plasma specific act., n.d.
55 33
1274 design protein synthesis procedure to simplify equation, n.d.
55 34
1275 thiopental anesthesia and protein synthesis, n.d.
55 35
1276 controal and protacaval shunt [photographs, negative], n.d.
55 36
1277 barbital foci in DG and MG [photographs, negatives], n.d.
55 37
1278 penicillin focus in DG and MG [photographs, negatives], n.d.
55 38
1279 developmental time course in kidney [photographs, negatives], n.d.
55 39
1280 developmental time course in brain [photographs, negatives], n.d.
55 40
1281 developmental time course in kidney [photographs, negatives], n.d.
55 41
1282 developmental time course in brain [photographs, negatives], n.d.
55 42
1283 antibody titration of GHBD in rat brain cytosol [photographs, negatives], n.d.
55 43
1284 developmental time course in kidney [photographs, negatives], n.d.
55 44
1285 developmental time course in brain [photographs, negatives], n.d.
55 45
1286 [photographs, negatives], n.d.
55 46
1287 effect of whisker stroking on blood flow in whisker-to-barrel pathway[photographs, negatives], n.d.
55 47
1303 [photographs], n.d.
55 48
1313 reaction sequence in amino acid incorporation into protein, n.d.
55 49
1314 reaction sequence in amino acid incorporation into protein, n.d.
55 50
1315 Lord Kelvin quote, n.d.
55 51
1316 C. W. Roy and C. S. Sherrington quote, n.d.
55 52
1317 cartoon by W. Miller, n.d.
55 53
1325 cat brain [photographs, negative], n.d.
55 54
1326 [photographs, negative], n.d.
55 55
1327 homogeneous and heterogeneous tissue model [photographs, negative], n.d.
55 56
1328 time course of measured radioactivity[photographs, negative], n.d.
55 57
1329 superior colliculus and lateral geniculate nucleus [photographs, negative], n.d.
55 58
1330 effect of n-monomethyl-L-arginine on mean arterial blood pressure in rats, n.d.
55 59
1331 effect of unilateral whisker stroking on blood flow in unstimulated side of whisker to barrel pathway, n.d.
55 60
1332 effects of nitric oxide synthase inhibitors on arterial pressure, n.d.
55 61
1333 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02, n.d.
55 62
1334 Distribution of N-methyl-Larginine between blood and brain 10 minutes after I.V. pulse, n.d.
55 63
1335 effects of systemic infusion of nitric oxide synthase inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stimulation, n.d.
55 64
1336 effects of intra-cisternal infusion of nitroarginine methylester on ICBF in whisker-barrel pathway during unilateral whisker stimulation in the unanesthetized rat, n.d.
55 65
1337 summary, n.d.
55 66
1338 effects of 5 percent carbon dioxide on physiological variables in rats, n.d.
55 67
1339 effects of 5 percent C02 on physiological variables in rats following systemic administration of nitric oxide inhibitors, n.d.
55 68
1340 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats, n.d.
55 69
1341 [photographs, negative], n.d.
55 70
1342 C. W. Roy and C. S. Sherrington quote, n.d.
55 71
1346 Kt for brain: plasma glucose transport, n.d.
55 72
1347 Kt for blood-brain barrier transport of glucose from methylglucose tissue:plasma distribution ratios, n.d.
55 73
1348 relationship of equilibrium methylglucose tissue:plasma distribution ratio to tissue glucose content in brain, n.d.
55 74
1349 effects of insulin on local rates of glucose utilization in conscious rat brain, n.d.
55 75
1350 effects of insulin-induced hypoglycemia on local rates of cerebral glucose utilization in the rat, n.d.
55 76
1351 brain glucose utilization in hyperglycemia [photographs, negative], n.d.
55 77
1352 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, n.d.
55 78
1353 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, n.d.
55 79
1354 effects of altered arterial blood tensions of respiratory gases on cerebral blood flow and related functions in normal young men, n.d.
55 80
1355 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats, n.d.
55 81
1356 brain glucose concentration and lumped constant, n.d.
55 82
1357 traits of portacaval-shunted rats, n.d.
55 83
1358 calculation of the rate of glucose utilization in brain, n.d.
55 84
1359 ammonia levels in control and portacaval-shunted rats, n.d.
55 85
1360 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment, n.d.
55 86
1361 steady state brain:plasma distribution ratios for [14C]methylglucose, n.d.
55 87
1362 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment, n.d.
55 88
1363 deoxyglucose and glucose, n.d.
55 89
1364 comparison of levels of ammonia, glucose and glutamine in various portacaval-shunted rats, n.d.
55 90
1365 glucose levels and lumped constant in portacaval shunted rats, n.d.
55 91
1366 effects of NOS inhibitor on increases in CBF induced by C02 inhalation in anesthetized ventilated rats, n.d.
55 92
1367 effects of chronic intraperitoneal administration of NO synthase inhibitor on enzyme activites in brain, n.d.
55 93
1368 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain, n.d.
55 94
1369 effects of intracisternal administration of NO synthase inhibitor on enzyme activities in brain, n.d.
55 95
1370 visual pattern discrimination task, n.d.
55 96
1371 section of the optic tract and corpus callosum 'blinds' the right hemisphere, n.d.
55 97
1373 theory - at equilibrium the rates of transport of methylglucose (MG), v*, to and from the brain tissue are equal, n.d.
55 98
1374 physiological variables before and after topical application of bicuculline and muscimol, n.d.
55 99
1375 preliminary experiments to evaluate the influence of bicuculline and muscimol on ICMRglc and steady state brain:plasma distribution ratio for [14C]methylglucose, n.d.
55 100
1376 fig. 1. Ce*/Cp* as function of Ce at Cp = 15.4 mM, n.d.
55 101
1377 fig. 2. Ce*/Cp* as function of Ce at Cp = 9.5 mM, n.d.
55 102
1378 fig. 3. Ce*/Cp* as function of Ce at Cp = 6.8 mM, n.d.
55 103
1379 fig. 4. Ce*/Cp* as function of Ce at Cp = 5.6 mM, n.d.
55 104
1380 fig. 5. Ce*/Cp* as function of Ce at Cp = 4.5 mM, n.d.
55 105
1381 fig. 6. Combined results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization, n.d.
55 106
1382 fig. 7. Combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and ICMRglc), n.d.
55 107
1383 conclusions, n.d.
55 108
1384 effects of chronic intraperitoneal administration of nitroarginine methyl ester (50mg/kg twice daily for 4 days) on increases in cerebral blood flow caused by breathing 5 percent C02, n.d.
55 109
1385 effect of intracisternal administration of nitroarginine methyl ester on nitric oxide synthase in brain, n.d.
55 110
1386 effect of chronic intraperitoneal administration of nitroarginine methyl ester on nitric oxide synthase in brain, n.d.
55 111
1387 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative], n.d.
55 112
1388 [14C]deoxyglucose autoradiographs of brain sections from a rat whose vibrissae on the left side were continually stroked [photographs, negative], n.d.
55 113
1389 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-metylarginine or NG-nitroarginine on arterial blood pC02 and pH, n.d.
55 114
1390 right-left differences in glucose utilization in primary motor (area 4) and premotor cortex (area 6) in unimanually active monkeys, n.d.
55 115
1391 right-left percent differences in glucose utilization in primary and secondary somatosensory cortex in unimanually active monkeys, n.d.
55 116
1392 effects of intravenous administration of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, n.d.
55 117
1393 effects of intracisternal administration of nitroarginine ME on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, n.d.
55 118
1394 assay conditions for brain nitric oxide synthase activity, n.d.
55 119
1395 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats, n.d.
55 120
1396 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02, n.d.
55 121
1397 effect of unilateral whisker stroking on ICBF in whisker-to-barrel pathway (untreated rats), n.d.
55 122
1398 effects of 5 percent C02 in inspired air on arterial pC02 and pH in normal control rats and in rats administered inhibitors of nitric oxide synthase intravenously, n.d.
55 123
1399 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats, n.d.
55 124
1400 [conscious vs. anesthetized glucose utilization [photographs, negative], n.d.
55 125
1401 relationships among glycolytic and oxidative rates of glucose utilization and ATP turnover, n.d.
55 126
1402 kinetic basis for obligatory increase in lactate/pyruvate concentrations during increases in oxidative glucose metabolism, n.d.
55 127
1403 relationship between oxygen and glucose metabolism in normal young adult human brain, n.d.
55 128
1404 cerebral blood flow and metabolic rate in humans with various disorders affecting mental state, n.d.
55 129
1406 relationship between cerebral oxygen consumption and glucose utilization in normal young adult man, n.d.
55 130
1407 energy metabolism per spike in dorsal horn, n.d.
55 131
1408 ICMRglc per spike in dorsal lumbar cord, n.d.
55 132
1431astrocytes - intracellular products, n.d.
55 133
1432 astrocytes + MSO - extracellular products, n.d.
55 134
1433 astrocytes + MSO - intracellular products, n.d.
55 135
1434 astrocytes + neurons - intracellular products, n.d.
55 136
1435 astrocytes + neurons + MSO - intracellular products, n.d.
55 137
1436 astrocytes + neurons + MSO - extracellular products, n.d.
55 138
1437 astrocytes + neurons - extracellular products, n.d.
55 139
1438 astrocytes - extracellular products, n.d.
55 140
1439 [14C]products (DPM), n.d.
55 141
1440 C02 fixation in primary CNS cultures, n.d.
55 142
1441 astroglia vs. neurons and astroglia, n.d.
55 143
1442 MIX-4: AAAnal IC and EC, n.d.
55 144
1443 K+ concentrations of astroglia and neurons, n.d.
55 145
1444 the effect of depolarizing agents on C02 fixation in astroglial cells, n.d.
55 146
1445 the effect of calcium on C02 fixation in astroglial cells, n.d.
55 147
1446 astroglia, fibroblasts, and neurons, n.d.
55 148
1447 [14C]deoxyglucose concentration, n.d.
55 149
1449 autoradiographic calibration [photographs, negatives], n.d.
55 150
1450 Aristotle quote, n.d.
55 151
1451 [14C]iodoantyiprine and [14C]deoxyglucose [photographs, negatives], n.d.
55 152
1452 glucose utilization during unilateral spreading depression in left hemisphere [photographs, negatives], n.d.
55 153
1453 percent activity newborn rat pup and 20 day rat pup [photographs, negatives], n.d.
55 154
1454 postnatal age activity [photographs, negatives], n.d.
55 155
1455 postnatal age activity [photographs, negatives], n.d.
55 156
1456 postnatal age activity [photographs, negatives], n.d.
55 157
1457 postnatal age and GHB and GABA concentrations [photographs, negatives], n.d.
55 158
1458 postnatal age and GHB concentration [photographs, negatives], n.d.
55 159
1459 postnatal age and activity [photographs, negative], n.d.
55 160
1460 apomorphine and ICMRglc [photographs, negative], n.d.
55 161
1461 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative], n.d.
55 162
1462 [photographs, negative], n.d.
55 163
1463 blood pressure responses to stimulation during electrode placement under anesthesia [photographs, negative], n.d.
55 164
1464 unilateral and bilateral lesions [photographs, negative], n.d.
55 165
1465 blood pressure and biphasic stimulation [photographs, negative], n.d.
55 166
1466 varied blood pressure and biphasic stimulation [photographs, negative], n.d.
55 167
1467 blood pressure responses [photographs, negative], n.d.
55 168
1468 unilateral and bilateral lesions [photographs, negative], n.d.
55 169
1469 [14C]iodoantypyrine and [14C]deoxyglucose [photographs, negative], n.d.
55 170
1470 [photographs, negative], n.d.
55 171
1471 [photographs, negative], n.d.
55 172
1472 postnatal age and ICPSleu [photographs, negative], n.d.
55 173
1473 postnatal age and ICPSleu [photographs, negative], n.d.
55 174
1474 postnatal age and CPSleu[photographs, negative], n.d.
55 175
1475 effects of chronic intraperitoneal nitroarginine on baseline and on increases in blood flow due to unilateral whisker stroking in four stations of the whisker-to-barrel pathway [photographs, negative], n.d.
55 176
1476 effects of intracisternally infused artificial CSF or nitroarginine on baseline and increases in blood flow due to unilateral stroking of whiskers in four stations of the whisker-to-barrel pathway [photographs, negative], n.d.
55 177
1477 effects of intravenous nitroarginine on baseline and increases in blood flow in four stations of the whisker-to-barrel pathway due to unilateral stroking of whiskers [photographs, negative], n.d.
55 178
1478 table 1. Effects of various treatments with nitroarginine on nitric oxide synthase activity in rat brain [photographs, negative], n.d.
55 179
1481 effects of extracellular potassium ion concentration on phosphorylation of 2-deoxyglucose in cultured neurons and astroglia [title page?], n.d.
55 180
1482 assay protocol, n.d.
55 181
1483 standard reaction mixture, n.d.
55 182
1484 conclusions, n.d.
55 183
1485 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia, n.d.
55 184
1486 cell cultures, n.d.
55 185
1487 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose, n.d.
55 186
1488 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deosyglucose in cultured astroglia, n.d.
55 187
1489 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia, n.d.
55 188
1490 effects of veratridine on phosphorylation of [14C]2-deoxyglucose, n.d.
55 189
1491 effects of extracellular potassium ion concentration on phosphorylation of [14C[-2-deoxyglucose, n.d.
55 190
1492 table 9. Cerebral blood flow and metabolic rate in humans with various disorders affecting mental state, n.d.
55 191
1493 table 4. Effects of insulin hypoglycemia on cerebral circulation and metabolism in humans, n.d.
55 192
1494 table 7. Effects of insulin in normoglycemia, insulin-induced hypoglycemia, and hyperglycemia on local cerebral glucose utilization in the rat, n.d.
55 193
1495 table 1. Effects of infusions of 2-deoxyglucose (500 mg/kg) on physiological variables, n.d.
55 194
1496 table 2. The effects of pharmacologic doses of 2-deoxyglucose (500 mg/kg) on local cerebral blood flow (ml/100 g/min), n.d.
55 195
1497 Ca standards and Ca standard curve [photographs, negative], n.d.
55 196
1498 Ca concentration gradients [photographs, negative], n.d.
55 197
1499 Frank and Ernest cartoon (1994), n.d.
55 198
1500 comic drawing of regions of the brain, n.d.
55 199
1501 plasma calcium concentrations and clearance of 45Ca from plasma, n.d.
55 200
1502 total calcium and integrated specific activity of 45Ca in arterial plasma as a function of age, n.d.
55 201
1503 total brain concentration, brain:plasma distribution ratios, apparent transfer coefficients, and net uptake of calcium into hand-dissected brain regions as a function of age, n.d.
55 202
1504 gradients of calcium transport in young, middle-aged, and old rats, n.d.
55 203
1505 rank order of regional uptake of calcium as a function of age, n.d.
55 204
1506 3-rate-constant (3K), 4-rate-constant (4K) model, and tissue heterogeneity (TH) model [negative], n.d.
55 205
1507 3K, 4K, and TH models [negative], n.d.
55 206
1508 3K model [negative], n.d.
55 207
1509 relationship between accumulated labeled and unlabeled lactate in cerebral cortex during spreading depression, n.d.
55 208
1510 3K, 4K, and TH models [negative], n.d.
55 209
1511 specific activities of lactate and glucose as functions of brain glucose level in activated (spreading depression) and control cerebral cortex, n.d.
55 210
1512 hypothetical reaction mechanism of enzymic NO formation, n.d.
55 211
1513 conscious and anesthetized glucose utilization, n.d.
55 212
1514 anonymous humorous quote, n.d.
55 213
1515 left-right (spreading depression vs. control) differences obtained with labeled deoxyglucose and glucose, n.d.
55 214
1516 brain:plasma distribution ratios for glucose (Ce/Cp) and [14C] deoxyglucose (Ce*/Cp*) and lambda (i.e., [Ce*/Cp*]/[Ce/Cp]) as functions of brain glucose content in warm- and cold-adapted, active control and hibernating squirrels, n.d.
55 215
1517 clearance of [14C]DG from squirrel plasma after an intravenous pulse, n.d.
55 216
1518 brain glucose level as a function of plasma glucose content in warm- and cold-adapted, active controls and hibernating squirrels, n.d.
55 217
1519 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc, n.d.
55 218
1520 direct chemical assays of concentrations of glucose, [14C]precursor, and 14C-labeled metabolites and calculated rates of glucose utilization in cerebral cortex during KCL-induced activation of CMRglc at 5-7 min after the pulse of [14C]precursor, n.d.
55 219
1521 levels of glucose and [14C]deoxyglucose in plasma and several brain regions of active and hibernating squirrels at 45 min after a pulse of [14C]deoxyglucose, n.d.
55 220
1523 brain:plasma distribution ratios for glucose and [14C]deoxyglucose and estimated values for the factor lambda and the lumped constant of the operational equation of the [14C]deoxyglucose method for active and hibernating squirrels, n.d.
55 221
1524 separation of 14C-labeled metabolites derived from [6-14C]glucose in the control and activated cortex, n.d.
55 222
1525 physiological variables in active and hibernating ground squirrels, n.d.
55 223
1526 differences in metabolic rate with the mean rate of barrels A1-3 and E1-3 as reference, n.d.
55 224
1527 metabolic rates in left (L) and right ( R) barrel cortex [negative], n.d.
55 225
1528 effect of NO synthase inhibition on autoregulation [photographs, negative], n.d.
55 226
1529 effects of intravenous infusion of epinephrine on physiological variables and CBF, n.d.
55 227
1530 effects of glutamate on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, n.d.
55 228
1531 effects of veratridine or monensin on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, n.d.
55 229
1532 effects of veratridine on phosphorylation of [14C]2-deoxyglucose, n.d.
55 230
1533 effects of veratridine on phosphorylation of [14C]2-deoxyglucose in cultured neurons and astroglia, n.d.
55 231
1534 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, n.d.
55 232
1535 effects of extracellular potassium ion concentration on phosophrylation of [14C]2-deoxyglucose in different types of cultured cells, n.d.
55 233
1536 effects of chronic treatment with L-NAME on ICMRglc - part 2, n.d.
55 234
1537 effects of chronic treatment with L-NAME on ICMRglc - part 1, n.d.
55 235
1538 effect of NO synthase inhibition on autoregulation of CBF, n.d.
55 236
1539 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, n.d.
55 237
1540 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in cultured astroglia, n.d.
55 238
1541 effects of chronic treatment with L-NAME on autoregulation of ICBF - part 1, n.d.
55 239
1542 effects of chronic treatment with L-NAME on physiological variables, n.d.
55 240
1543 effects of chronic treatment with L-NAME on physiological variables measured just prior to the infusion of [14C]deoxyglucose, n.d.
55 241
1544 effects of chronic treatment with L-NAME on autoregulation of ICBF - part 2, n.d.
55 242
1545 effects of insulin on physiological variables and CBF in euglycemic rats, n.d.
55 243
1546 effect of insulin-induced hypoglycemia on cerebral blood flow in conscious rats, n.d.
55 244
1547 effect of pharmacological doses of deoxyglucose on CBF in conscious rats, n.d.
55 245
1548 effect of insulin on cerebral blood flow in euglycemic rats, n.d.
55 246
1549 relationship between CBF and [K+] in insulin-induced hypoglycemia, n.d.
55 247
1550 relationship between arterial pH and CBF in insulin-induced hypoglycemia, n.d.
55 248
1551 relationship between plasma lactate and CBF in insulin-induced hypoglycemia, n.d.
55 249
1552 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, n.d.
55 250
1553 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, n.d.
55 251
1554 effects of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking, n.d.
55 252
1555 arterial plasma valine concentration [photographs, negative], n.d.
55 253
1556 postnatal age and ICPSleu [photographs, negative], n.d.
55 254
1557 arterial plasma insulin level, arterial plasma glucose concentration, and arterial plasma valine concentration [photographs, negative], n.d.
55 255
1558 postnatal age and ICPSleu [photographs, negative], n.d.
55 256
1559 acute, chronic, and residual cocaine and saline vehicle [photographs, negative], n.d.
55 257
1560 behavioral scores and days of treatment for chronic vehicle and chronic cocaine [photographs, negative], n.d.
55 258
1561 postnatal age and CPSleu [photographs, negative], n.d.
55 259
1562 plasma, extracellular space, and intracellular space [photographs, negative], n.d.
55 260
1563 lesion of fastigial nucleus and autoregulation of CBF [photographs, negative], n.d.
55 261
1564 table 1. Physiological variables measured 45 seconds after starting stimulation and 15 seconds prior to the measurement of local cerebral blood flow or local cerebral glucose utilization, n.d.
55 262
1565 table 2. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral blood flow, n.d.
55 263
1566 table 3. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral glucose utilization, n.d.
55 264
1567 table 4. Effects of lesions of the cerebellar fastigial nucleus on physiological variables measured just before local cerebral blood flow measurement, n.d.
55 265
1568 table 5. Effects of left unilateral lesion of the cerebellar fastigial nucleus on local cerebral blood flow, n.d.
55 266
1569 table 6. Effects of lesions of the cerebellar fastigial nucleus on local cerebral blood flow, n.d.
55 267
1570 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat, n.d.
56 1
1571 table 3. Effects of increasing extracellular potassium ion concentration on rates of [14C]deoxyglucose phosphorylation in cultured astroglia [photographs, negative], n.d.
56 2
1572 table 2. Influ4ence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro, n.d.
56 3
1573 table 1. Representative values for local cerebral glucose utilization in normal conscious albino rat and monkey, n.d.
56 4
1574 change in [14C] DG phospohrylation (percentage), n.d.
56 5
1575 change in [14C] DG phospohrylation (percentage), n.d.
56 6
1576 effect of pharmacological dose of doexyglucose on cerebral blood flow, n.d.
56 7
1577 superior colliculus and lateral geniculate nucleus, n.d.
56 8
1578 veratridine and monensin [photographs, negative], n.d.
56 9
1579 neuronal, neuronal-astroglial, and astroglial extracellular potassium ion concentration [photographs, negative], n.d.
56 10
1580 [14C]deoxyglucose-6-phosphate with and without glutamate [photographs, negative], n.d.
56 11
1581 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc, n.d.
56 12
1582 loss of labeled metabolites of [6-14C]glucose during bilateral spreading cortical depression, n.d.
56 13
1585 lactate loss from brain during bilateral spreading cortical depression+, n.d.
56 14
1587 transport of 14C-labeled lactate and insulin in brain during a 10 min interval, n.d.
56 15
1590 Ce*/Cp* as function of Ce at Cp = 5.6 mM, n.d.
56 16
1591 combined experimental results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization, n.d.
56 17
1592 nucleus accumbens and sensory motor cortex, n.d.
56 18
1593 caudate-putamen and globus pallidus, n.d.
56 19
1594 ventral N. thalamus and internal capsule, n.d.
56 20
1595 average whole brain CBF and insulin-treated euglycemic, n.d.
56 21
1596 average whole brain CBF with saline + DG and L-NAME + DG, n.d.
56 22
1597 average whole brain CBF and arterial plasma glucose concentration (mM), n.d.
56 23
1598 average whole brain CBF and arterial plasma glucose concentration (mM), n.d.
56 24
1599 table 1. Effects of insulin on physiological variables measured just before CBF measurement, n.d.
56 25
1600 table 2. Effects of insulin on physiological rats variables in euglycemic rats, n.d.
56 26
1601 table 3. Effects of pharmacological doses of DG on physiological variables and CBF, n.d.
56 27
1602 table 4. Effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats, n.d.
56 28
1603 table 5. Effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement, n.d.
56 29
1605 effects of insulin on physiological variables measured just before CBF measurement, n.d.
56 30
1606 effects of insulin on physiological variables in euglycemic rats, n.d.
56 31
1607 effects of pharmacological doses of DG on physiological variables and CBF, n.d.
56 32
1608 effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement, n.d.
56 33
1609 effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats, n.d.
56 34
1610 table 2. Effects of inhibitors of nitric oxide synthase on physiological variables during inhalation of room air or 5 percent C02, n.d.
56 35
1612 distribution of [U-14C]lactate and its metabolites in brains of anesthetized rats at 10 min after an intracerebral injection, n.d.
56 36
1613 effect of chronic intraperitoneal administration of nitroarginine on CBF and on increases in CBF produced by 5 percent C02, n.d.
56 37
1614 conclusions, n.d.
56 38
1619 newborn astroglia, n.d.
56 39
1620 extracellular and intracellular astroglia and neurons, n.d.
56 40
1640 effects of intravenous infusions of epinephrine on cerebral glucose utilization, n.d.
56 41
1641 effects of intravenous infusions of epinephrine on cerebral blood flow, n.d.
56 42
1642 effects of caffeine on CBF enhancement by insulin-induced hypoglycemia, n.d.
56 43
1643 effects of glibenclamide on CBF enhancement by insulin-induced hypoglycemia, n.d.
56 44
1644 CBF as a function of plasma glucose concentration, n.d.
56 45
1645 CBF as a function of plasma glucose concentration, n.d.
56 46
1646 CBF as a function of plasma glucose concentration, n.d.
56 47
1647 CBF as a function of arterial glucose concentration, n.d.
56 48
1648 CBF vs plasma glucose concentration in insulin-treated rats without and after pretreatment with nitroarginine, n.d.
56 49
1649 effect of insulin on CBF in euglycemic rats, n.d.
56 50
1650 arterial plasma glucose and catecholamines induced by glucoprivation due to insulin administration or pharmacological doses of deoxyglucose, n.d.
56 51
1651 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by pharmacological doses of 2-deoxyglucose, n.d.
56 52
1652 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by insulin-induced hypoglycemia, n.d.
56 53
1653 [14C]deoxyglucose-6-phosphate and glutamate [photographs], n.d.
56 54
1654 effects of insulin on physiological variables in euglycemic rats, n.d.
56 55
1655 diffusion-equilibrium blood flow model, n.d.
56 56
1657 effects of caffeine on local cerebral blood flow during functional activation of whisker-barrel pathway, n.d.
56 57
1658 calculated and measured methylglucose distribution ratio, n.d.
56 58
1659 calculated and measured brain glucose content, n.d.
56 59
1660 control of brain glucose level mainly by supply (constant demand), n.d.
56 60
1661 control of brain glucose level mainly by demand (constant supply), n.d.
56 61
1662 table 2. Influences of bicuculline and muscimol on rate of glucose utilization and methylglucose brain:plasma distribution ratio, n.d.
56 62
1663 table 1. Physiological variables in animals studied with topical applications of bicuculline or muscimol, n.d.
56 63
1664 diffusion-equilibrium blood flow model, n.d.
56 64
1665 average whole brain CBF and glibenclamide, n.d.
56 65
1666 average whole brain CBF and caffeine, n.d.
56 66
1667 concluding remarks, n.d.
56 67
1668 cerebral circulation and metabolism during deep sleep, n.d.
56 68
1669 local cerebral glucose utilization in non-rapid eye movement sleep in monkeys, n.d.
56 69
1670 cerebral circulation and metabolism during sleep and mental 'work', n.d.
56 70
1671 cerebral circulation and metabolism in schizophrenia and LSD-induced psychotomimetic state, n.d.
56 71
1672, n.d.
56 72
1673 rates of leucine incorporation and weighted percentage time in deep sleep, n.d.
56 73
1674 effects of catecholamines on cerebral circulation and metabolism, n.d.
56 74
1675 protein synthesis in deep sleep, n.d.
56 75
1676 table II. Cerebral nutritional insufficiency and mental state, n.d.
56 76
1677 table IV. Cerebral circulation and metabolism in normal aging, arteriosclerosis and chronic brain syndrome, n.d.
56 77
1679 hyperpolarization, relaxation, and vasodilation, n.d.
56 78
1680 table 2. Relationship between oxygen and glucose metabolism in normal young adult human brain, n.d.
56 79
1681 table 1. Substances utilized or produced by normal young adult human brain, n.d.
56 80
1682 relationships among glycotic and oxidative rates of glucose utilization and ATP turnover in normal conscious human brain, n.d.
56 81
1683 energy metabolism per spike, n.d.
56 82
1684 energy metabolism per Hz, n.d.
56 83
1686 table II Substrates of cerebral energy metabolism in human adults during prolonged starvation, n.d.
56 84
1687 molecular layer of hippocampus, n.d.
56 85
1688 cerebral blood flow, n.d.
56 86
1689 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation, n.d.
56 87
1690 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing, n.d.
56 88
1691 spinal trigeminal nucleus, principal sensory trigeminal nucleus, VPM thalamic nucleus, and somatosensory cortex, barrel field [negatives], n.d.
56 89
1692 cerebral blood flow [negatives], n.d.
56 90
1693 table 1. Effects of scopolamine on physiological variables, n.d.
56 91
1694 C. S. Roy and C. S. Sherrington quote, n.d.
56 92
1695 C. S. Roy and C. S. Sherrington quote, n.d.
56 93
1696 average whole brain CBF and caffeine and glibenclamide, n.d.
56 94
1697 average whole brain CBF and arterial plasma glucose concentration, n.d.
56 95
1698 table 1. Effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow, n.d.
56 96
1699 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, and somatosensory cortex barrel field, n.d.
56 97
1700 cerebellar white matter, caudate-putamen, primary motor cortex, and accumbens nucleus core, n.d.
56 98
1701 table 2. Effects of insulin-induced hypoglycemia and pharmacological doses of 2-doexyglucose on adenosine, inosine, and hypoaxanthine levels in conscious rat brain, n.d.
56 99
1702 weighted average whole brain blood flow and epinephrine, n.d.
56 100
1703 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing, n.d.
56 101
1704 resources - Louis Sokoloff, M.D. - Laboratory of Cerebral Metabolism, n.d.
56 102
1705 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation, n.d.
56 103
1707 resources - Louis Sokoloff, M.D. - Laboratory of Cerebral Metabolism, n.d.
56 104
1708 compartmental models that do not meet the conditions for application of spectral analysis to total tissue activity, n.d.
56 105
1709 compartmental models that satisfy the conditions for application of spectral analysis to total tissue activity, n.d.
56 106
1710 compartmental systems formed by removing a link from a strongly connected noncyclic system, n.d.
56 107
1711 construction of the sign-symmetric completion of a compartmental system, n.d.
56 108
1712 strongly connected noncyclic compartmental systems, n.d.
56 109
1713 residual intracellular 2-[14C]DG-6-P after extended incubation, n.d.
56 110
1714 [14C] glucose standard, zero time, 5 minute incubation, 10 minute incubation, and 15 minute incubation, n.d.
56 111
1715 phosphorylation reaction and phosphatase activity, n.d.
56 112
1716 time course of 3H/14C ratio during incubation of astroglia with [2-3H]Glucose and [U-14C]glucose, n.d.
56 113
1717 residual intracellular 2-[14C]DG-6-P after extended incubation, n.d.
56 114
1718 active and hibernating effluent volumes, n.d.
56 115
1719 ribosomes and [3H]-leucine incorporation, n.d.
56 116
1720 active and hibernating [3H]-leucine incorporation, n.d.
56 117
1721 molecular mechanisms in physiological regulation of cerebral blood flow and metabolism [title page?], n.d.
56 118
1722 background, n.d.
56 119
1723 effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and optharmacologic doses of 2-deoxyglucose on systemic physiological variables that might influence cerebral blood flow, n.d.
56 120
1724 effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow, n.d.
56 121
1725 recent and current research, n.d.
56 122
1726 conclusions, n.d.
56 123
1728 active and hibernating [3H]-leucine incorporation, n.d.
56 124
1729 intracellular 14C DPM and 3H DPM distances from origin, n.d.
56 125
1730 intracellular and extracellular 14C DPM per [symbol]g protein, n.d.
56 126
1731 intracellular 14C DPM distances from origin, n.d.
56 127
1732 intracellular and extracellular 14C DPM per [symbol]g protein, n.d.
56 128
1733 table3. Relationship between cerebral oxygen consumption and glucose utilization in a normal young adult man, n.d.
56 129
1734 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, n.d.
56 130
1735 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, n.d.
56 131
1736 intracellular and extracellular 14C DPM per [symbol]g protein, n.d.
56 132
1737 intracellular 14C DPM distances from origin, n.d.
56 133
1738 extracellular 14C DPM distances from origin, n.d.
56 134
1739 intracellular and extracellular 14C DPM per [symbol]g protein, n.d.
56 135
1740 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time, n.d.
56 136
1741 intracellular 14C DPM and 3H DPM distances from origin, n.d.
56 137
1742 table 1. Physiological variables immediately before measurement of cerebral blood flow, n.d.
56 138
1743 table 2. Effects of caffeine on CBF during stimulation of vibrissae on left side of face in structures outside whisker-barrel pathway, n.d.
56 139
1744 table 3. Effects of caffeine on activation of local cerebral glucose utilization (ICMRglc) by vibrissal stimulation in whisker-to-barrel cortex sensory pathway, n.d.
56 140
1745 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, n.d.
56 141
1746 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, n.d.
56 142
1747 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, n.d.
56 143
1748 intracellular 14C DPM and 3H DPM distances from origin, n.d.
56 144
1749 intracellular and extracellular 14C DPM per [symbol]g protein, n.d.
56 145-148
1750-1753 extracellular 14C DPM distances from origin, n.d.
56 149
1754 time courses of intracellular and extracellular 14C contents - standard assay conditions, n.d.
56 150
1755 extracellular 14C DPM distances from origin, n.d.
56 151
1756 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex, n.d.
56 152
1757 table 1. Physiological variables immediately before measurement of cerebral blood flow, n.d.
56 153
1758 diffusion-equilibrium blood flow model, n.d.
56 154
1759 table 1. The effect of extracellular potassium concentration on lactate formation in astroglial cells in culture, n.d.
56 155
1760 table 2. The effect of extracellular potassium on C02 fixation and on lactate formation in astroglial cells in culture, n.d.
56 156
1761 table 3. Products formed by astroglial cells incubated with 14C-labeled bicarbonate: the effect of increased extracellular potassium, n.d.
56 157
1762 table 4. Glucose utilization in cells in culture, n.d.
56 158
1763 table 5. The effect of L-lactate on the oxidation of D-Glucose (2.5mM) to C02, n.d.
56 159
1764 table 6. The effect of D-Glucose on the oxidation of L-lactate (2mM) to C02, n.d.
56 160
1765 Ce*/Cp* as function of Ce at Cp = 6.8 mM, n.d.
56 161
1766 Ce"/Cp* as function of Ce at Cp = 4.5 mM, n.d.
56 162
1767 frequency of stimulation of glucose utilization [photographs, negative], n.d.
56 163
1768 functional plasticity in barrel cortex after depression, n.d.
56 164
1769 combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and CMRglc), n.d.
56 165
1770 selective trapping of 45Ca during metabolic activation [photograph], n.d.
56 166
1771 selective trapping of 45Ca during metabolic activation [photograph], n.d.
56 167
1772 effect of unilateral visual stimulation on glucose utilization, effect of visual stimulation on the increase in glucose utilization in superior colliculus, relative increase in glucose utilization in stimulated superior colliculus, n.d.
56 168
1773 table 1. Influence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro, n.d.
56 169
1774 diagram of veins and sinuses of the human brain [photograph], n.d.
60
071053 - autoradiographs, n.d.
60
071753A - RA9 [photograph, negative], n.d.
60
071753A - 10 [photograph, negative], n.d.
60
071753A - 17 [photograph, negative], n.d.
60
071753A - 26 [photograph, negative], n.d.
60
071753A - RA27 [photograph, negative], n.d.
60
071753A - RA29 [photograph, negative], n.d.
60
071753B [photographs, negatives], n.d.
60
072453A #1 [photograph, negative], n.d.
60
072453A #2 [photograph, negative], n.d.
60
072453A #3 [photograph, negative], n.d.
60
072453A #5 [photograph, negative], n.d.
60
072453A [photograph, negative], n.d.
60
072453A [photograph, negative], n.d.
60
072453A [photograph, negative], n.d.
60
072453B - no densitometry [photograph, negative], n.d.
60
072453B #4 RA6 [negative], n.d.
60
073053A #1 [photograph, negative], n.d.
60
073053A #2 [photograph, negative], n.d.
60
073053A #3 [photograph, negative], n.d.
60
073053A #5 [photograph, negative], n.d.
60
073053A #6 [photograph, negative], n.d.
60
073053A #7 [photograph, negative], n.d.
60
073053A #8 [photograph, negative], n.d.
60
073053B - 9 [photograph, negative], n.d.
60
073053B - 10 [photograph, negative], n.d.
60
073053B - 11 [photograph, negative], n.d.
60
073053B - 12 [photograph, negative], n.d.
60
073053B - 13 [photograph, negative], n.d.
60
073053B - 14 [photograph, negative], n.d.
60
073053B - 15 [photograph, negative], n.d.
60
073053B - 16 [photograph, negative], n.d.
60
080653A - AR17 [photograph, negative], n.d.
60
080653A - AR18 [photograph, negative], n.d.
60
080653A - AR19 [photograph, negative], n.d.
60
080653A - AR20 [photograph, negative], n.d.
60
080653A - AR21 [photograph, negative], n.d.
60
080653A - AR22 [photograph, negative], n.d.
60
080653A - AR23 [photograph, negative], n.d.
60
080653A - AR24 [photograph, negative], n.d.
60
080653A - AR25 [photograph, negative], n.d.
60
080653A - AR26 [photograph, negative], n.d.
60
080653A - AR27 [negative], n.d.
60
080653A - AR28 [photograph, negative], n.d.
60
080653A - AR29 [photograph, negative], n.d.
60
080653B [photographs, negatives], n.d.
60
081353 [negatives], n.d.
60
5613001 - cat 40s-10 [negative], n.d.
60
5613002 - 3 C02-10 [negative], n.d.
60
5613003 - 5 C02-10 [negative], n.d.
60
5613004 - 3 02-10 [negative], n.d.
60
5613005 - 2 C02-10 [negative], n.d.
60
5613006 - CT6 C02-10 [negative], n.d.
60
5613007 - 6 C02-10; 4 02-10 [negative], n.d.
60
5613008 - 4 C0-10 [negative], n.d.
60
564102 [negative], n.d.
60
564103 [negative], n.d.
60
564104 [negative], n.d.
60
564105 [negative], n.d.
60
564106 [negative], n.d.
60
564101 [negative], n.d.
 
Cat
60
5612701 - cat 5 W2-5 [negative], n.d.
60
5612702 - cat SCL 2 [negative], n.d.
60
5612703 - cat SCL 4 [negative], n.d.
60
5612704 - cat 102-10 [negative], n.d.
60
5612705 - cat SCL 8 [negative], n.d.
60
5612706 - cat SCL 15 [negative], n.d.
60
5612707 - cat 202-10 [negative], n.d.
60
5612708 - cat 1 C02-5 [negative], n.d.
60
5612709 - cat SCL 6 [negative], n.d.
60
5612710 - cat SCL 3 [negative], n.d.
60
5612711 - cat SCL 4 [negative], n.d.
60
5612712 - cat 1 C02-10 [negative], n.d.
60
5612713 - control cat 2 02-10, 1 C02-10 [negative], n.d.
60
5612714 - cat 4 C02-5 [negative], n.d.
60
5612715 - cat 5 SCL [negative], n.d.
60
5612716 - cat 2 C02-5 [negative], n.d.
60
5612717 - cat 14 SCL [negative], n.d.
60
5612718 - cat 3 C02-5 [negative], n.d.
60
5612719 - cat 13 SCL [negative], n.d.
60
5612720 - cat SCL 12 [negative], n.d.
60
5612721 - cat SCL 1 [negative], n.d.
60
5612722 - cat 6 C02-5 [negative], n.d.
60
Cat no. 1 - 12/3/53 [negatives]
60
Cat no. 2 [negatives], n.d.
60
Cat no. 3 - 12/17/53 [negatives]
60
Cat no. 4 - 2/17/53 [negatives]
60
Cat no. 5 - 1/7/54 [negatives]
60
Cat no. 6 - 1/7/54 [negatives]
60
Cat no. 7 - 1/14/54 [negatives]
60
Cat no. 7 and 8 - heart and kidney [negatives], n.d.
60
Cat no. 8 - 1/14/54 [negatives]
60
Cat no. 9 - 2/4/54 [negatives]
60
Cat no. 10 - 2/4/54 [negatives]
60
Cat no. 11 - 2/11/54 [negatives]
60
Cat no. 12 - 2/11/54 [negatives]
60
Cat no. 13 - saturation - 2/12/54 (#2 and 22 taken 5/21/57) [negatives], 1954-1957
60
Cat no. 14 - saturation - 2/12/54 (#9 taken 5/21/57) [negatives], 1954-1957
60
Cat no. 15 - 2/25/54 - cochlea destroyed [negatives]
60
Cat no. 16 - 2/25/54 - cochlea destroyed [negatives]
60
Cat no. 17 - 3/4/54 - cochlea destroyed [negatives]
60
Cat no. 18 - 3/4/54 - cochlea destroyed [negatives]
60
Cat no. 19 - 5/20/54 [negatives]
60
Cat no. 20 - 5/20/54 [negatives]
60
Cat no. 21 - 5/29/54 - lambda [negatives]
60
Cat no. 23 - 6/3/54 [negatives]
60
Cat no. 23 - 6/3/54 - lambda [negatives]
60
Cat no. 24 - 6/3/54 (#11 and 16 in slides) [negatives]
60
Cat no. 25 - repeat (air exposure) - 6/9/54 [negatives]
60
Cat no. 26 - 6/9/54 [negatives]
60
Cat no. 26 - 6/9/54 - reput [negatives]
60
Cat no. 27 - 6/17/54 [negatives]
60
Cat no. 28 - 6/17/54 [negatives]
60
Cat no. 29 - 6/24/54 [negatives]
60
Cat no. 30 - 6/24/54 [negatives]
60
Cat no. 31 - 7/1/54 - films 41, 45, 49 taken for England [negatives]
60
Cat no. 32 - 7/1/54 [negatives]
60
Cat no. 33 - 7/8/54 [negatives]
60
Cat no. 34 - 7/18/54 - for illustrations #17 and 20 in slides [negatives]
60
Cat no. 35 - 6/9/54 - lampda [negatives]
60
Cat no. 35 - 7/15/54 [negatives]
60
Cat no. 36 - 7/15/54 (#45 to England) [negatives], 1954
58
Cat 1 02 10 [negatives], n.d.
58
Cat 2 02-10 [negatives], n.d.
58
Cat 2 02-10 control for 2 02-10, 1C02-10 [negatives], n.d.
58
Cat 3 02-10 - fig. 1A [negatives], n.d.
58
Cat 4 02-10 [negatives], n.d.
58
Control for Cat 4 02-10 and 6 C02-10 [negatives], n.d.
58
Cat 5 02-10 - control 10 C02 5 [negatives], n.d.
58
Cat 6 02-10 [negatives], n.d.
58
Cat 7 02-10 [negatives], n.d.
58
Cat 1 02-100 - May 14 [negatives], 1957
58
Cat 2 02-100 [negatives], n.d.
58
Cat 3 02-100 [negatives], n.d.
58
Cat 5 02-100 [negatives], n.d.
58
Cat 6 02-100 [negatives], n.d.
58
Cat 7 02-100 (control) [negatives], n.d.
58
Cat 8 02-100 [negatives], n.d.
58
Cat 9 02-100 [negatives], n.d.
58
Cat 10 02-100 [negatives], n.d.
58
Cat 1 C02-5 - used #20 for slide for fed. meet - 4/15/57 [negatives], 1957
58
Cat 2 C02-5 - 9/26/56 [negatives], 1956
58
Cat 3 C02-5 [negatives], n.d.
58
Cat 4 C02-5 [negatives], n.d.
58
Cat 5 C02-5 [negatives], n.d.
58
Cat 5 C02-5 - film too dark, other film of this cat more acceptable [negatives], n.d.
58
Cat 6 C02-5 [negatives], n.d.
58
Cat 7 C02-5 [negatives], n.d.
58
Cat 8 C02-5 [negatives], n.d.
58
Cat 9 C02-5 [negatives], n.d.
58
Cat 10 C02-5 [negatives], n.d.
58
Cat 11 C02-5 [negatives], n.d.
58
Cat 12 C02-5 [negatives], n.d.
58
Cat 13 C02-5 [negatives], n.d.
58
Cat 14 C02-5 [negatives], n.d.
58
Cat 15 C02-5 [negatives], n.d.
58
Cat 16 C02-5 [negatives], n.d.
58
Cat 17 C02-5 - May 14 [negatives], 1957
58
Cat 1 C02-10 - film 27 used for England, used film 28 for slide fed meet. 4/15/57 [negatives], 1957
58
Cat 2 C02-10 - make darkest - fig 1C [negatives], n.d.
58
Cat 3 C02-10 [negatives], n.d.
58
Cat 4 C02-10 [negatives], n.d.
58
Cat 5 C02-10 - fig 1B [negatives], n.d.
60
Cat 1 SCL - 5/8/56 - unstimulated control (#8 to England) [negatives], 1956
60
Cat 2 SCL - 5/8/56 - 5' retinal stimulation (#19 and 21 to England) [negatives], 1956
60
Cat 3 SCL - 5/11/56 - stimulated cat [negatives], 1956
60
Cat 4 SCL - 5/11/56 - unstimulated cat (#20 to England) [negatives], 1956
60
Cat 5 SCL - 5/24/56 - stimulated [negatives], 1956
60
Cat 6 SCL - 5/24/56 [negatives], 1956
60
Cat 7 SCL - 7/3/56 - control [negatives], 1956
60
Cat 8 SCL - 7/3/56 - 5' retinal stimulation [negatives], 1956
60
Cat 9 SCL - 7/26/56 - stimulated 10' [negatives], 1956
60
Cat 11 SCL - 10 minutes stimulation - 7/30/56 [negatives], 1956
60
Cat 12 SCL - 5' retinal stimulation - 9/11/56 [negatives], 1956
60
Cat 13 SCL - 9/11/56 - control for 5" stimulation (note: film #24 not used) [negatives], 1956
58
Cat 1-SCLN (too dark to use) [negatives], n.d.
58
Cat 3-SCLN [negatives], n.d.
59
Cat 1ON - 1/26/56 - stimulated optic nerve [negatives], 1956
59
Cat 2ON - 1/26/56 - optic nerve crushed [negatives], 1956
59
Cat 1P - 12/16/54 - pentothal - #8 to slide [negatives], 1954
59
Cat 2 - 12/23/57 - pentothal [negatives], 1957
59
Cat 3P - 12/30/54 - cat 3 pentothal [negatives], 1954
59
Cat 4P - 12/30/54 - pentothal [negatives], 1954
59
Cat 5P - 1/6/55 - pentothal cat [negatives], 1955
59
Cat 6P - 1/6/55 - pentothal cat [negatives], 1955
59
Cat 7P - 1/13/55 - pentothal [negatives], 1955
59
Cat 8P - 1/13/55 - pentothal [negatives], 1955
59
Cat 11P - 2/4/55 - pentothal [negatives], 1955
59
Cat 12P - 2/4/55 - pentothal [negatives], 1955
59
Cat 13P - 2/7/55 [negatives], 1955
59
Cat 14P - 2/17/55 [negatives], 1955
59
Cat 1PS - 5/11/55 - film series "a" [negatives], 1955
59
Cat 1PS - 5/11/55 [negatives], 1955
59
Cat 2PS - 5/11/55 - film series "a" [negatives], 1955
59
Cat 2PS - 5/11/55 [negatives], 1955
59
Cat 3PS - 5/12/55 [negatives], 1955
59
Cat 4PS - 5/12/55 [negatives], 1955
59
Cat 5PS - 5/13/55 - negative #3 and 6 - make into slides [negatives], 1955
59
Cat 1V - 10/20/55 (films 23 and 24 out of order) [negatives], 1955
59
Cat 2V - 10/20/55 - (films 21 and 22 were out of order) [negatives], 1955
59
Cat 3V - 10/24/55 [negatives], 1955
59
Cat 4V - 10/24/55 [negatives], 1955
59
Cat 5V - 10/26/55 [negatives], 1955
59
Cat 5V - 10/26/55 [negatives], 1955
59
Cat 6V - 10/26/55 - lost tissue section [negatives], 1955
59
Cat 7V - 11/16/55 - films too light [negatives], 1955
59
Cat 7V - films "A" repeat - 11/16/55 [negatives], 1955
59
Cat 8V - 11/16/55 [negatives], 1955
59
Cat 9V - 11/17/55 [negatives], 1955
59
Cat 10V - 11/17/55 [negatives], 1955
59
Cat 11V - 11/23/55 [negatives], 1955
59
Cat 12V - 11/23/55 [negatives], 1955
59
Cat 1VP - 1/19/56 - film 18 not used [negatives], 1956
59
Cat 2VP - 1/19/56 [negatives], 1956
59
Cat 3VP - 1/20/56 - not stimulated visually [negatives], 1956
59
Cat 3VP and Cat 4VP - 1/20/56 - visually stimulated [negatives], 1956
59
Cat L1(a) - 7/7/55 [negatives], 1955
59
Cat L1 - 7/7/55 [negatives], 1955
59
Cat L2 - 7/7/55 [negatives], 1955
59
Cat L4 - 7/16/55 [negatives], 1955
59
Cat L5 - 7/21/55 [negatives], 1955
59
Cat L6 - "Lou" [negatives], n.d.
59
Cat L7 - 7/28/55 [negatives], 1955
59
Cat L8 - 7/28/55 [negatives], 1955
 
P
56 170
P 107 diazepam vs. control [photographs], n.d.
56 171
P 108 D and M lesion vs. control [photograph], n.d.
56 172
P 109 morphine vs. control [photographs], n.d.
56 173
P 110 LBH lesion vs. control [photographs], n.d.
56 174
P 163 arumd (Kennedy) [photographs], n.d.
56 175
P 192 thiopental rat [photographs], n.d.
 
SM
56 176
SM-3 [photographs], n.d.
56 177
SM-6 (both eyes patched) [photographs, negatives], n.d.
56 178
SM-12 [photographs], n.d.
56 179
SM-13 left eye enucleation [photograph], n.d.
56 180
SM-14 [photograph], n.d.
56 181
SM-21, n.d.
56 182
SM-21 rt. eye enucleation [photographs, negative], n.d.
56 183
SM-23 control [photographs, negatives], n.d.
56 184
SM-25 [photographs], n.d.
56 185
SM-26 eye patched [photographs, negative], n.d.
56 186
SM-27 [photographs, negative], n.d.
56 187
SM-28 long term monocular occlusion [photographs, negative], n.d.
56 188
SM-29 [photographs, negative], n.d.
56 189
SM-33 [photographs, negative], n.d.
56 190
SMII -- both eyes open before rotatory screen [photographs, negatives], n.d.
 
Unnumbered
56 191
Unidentified negatives [photographs, negative], n.d.
60
[unidentified] [negatives], n.d.
60
[unidentified] [negatives], n.d.
56 192
A/V DG plasma concentration in cat [photographs], n.d.
56 193
ARC 146A Stds. (OMI film), 1985-1986
56 194
Blood flow in anesthetized rats [photographs, negatives], n.d.
56 195
CBF and CMR 02 [photographs, negatives], n.d.
56 196
CBF and CMR 02 [photographs, negatives], n.d.
56 197
Circulatory system of the human head [photographs, negative], n.d.
56 198
Cocaine [photograph], n.d.
56 199
Crop [photographs, negative], n.d.
60
Densitometric calibration control - 6/18/54 - 9 stds [negative], 1954
56 200
Derivation of Patlak plot [photographs], n.d.
56 201
Effect of morphine on glucose utilization [photographs], n.d.
56 202
Effective rate "constant" vs. time [photographs, negative], n.d.
56 203
Electrophoretic patterns of purified HMBP's [photographs, negatives], n.d.
56 204
Exposure [negative], 1988
58
1st attempt to judge if the krypton 85 diffuses out of std with sawing - too dark, probably not [negatives], n.d.
58
2nd attempt to judge if Kr85 diffuses from head with sawing - not as can be determined [negatives], n.d.
56 205
Human central anterior circulation [photographs, negative], n.d.
56 206
Hypophysis [photographs], n.d.
56 207
Hypothalamus (insulin effect on LGU) [photographs, slide], n.d.
56 208
Joke: "May be on to something….." [negative], n.d.
56 209
LCBF [photographs, negatives], 1971
56 210
LCBF in mice [photographs, negatives], n.d.
56 211
LCGU in sup. collic. and lateral geniculate nucleus [photographs, negative], n.d.
56 212
Lateral surface of the macaque brain [negatives], n.d.
56 213
Leg blood flow metabolism [photographs, negatives], n.d.
56 214
Locus coeruleus [photographs], n.d.
56 215
MEG of rat L + R enucleation - sup. col. only - test photos [negatives], n.d.
60
Materials for slides, n.d.
56 216
Methods fig. [photographs, negatives], n.d.
56 217
Misc. [negatives], n.d.
56 218
Model and operational equation for equilibrium method for the determination of local cerebral blood flow, n.d.
56 219
Monkey not working [photographs], n.d.
56 220
Monkey put. in Parkinsonism [photographs, negative], n.d.
56 221
Monkey using lt. arm suppl. motor ctx. [photographs], n.d.
56 222
Motor cortex [photographs, negative], n.d.
56 223
Moving lt. arm and inactive [photographs, negative], n.d.
59
Name - Seymour [negatives], n.d.
59
Name - Lou [negatives], n.d.
59
Name - Bill [negatives], n.d.
59
Name - Bud [negatives], n.d.
59
Name - Walt [negatives], n.d.
59
Name - Darob [negatives], n.d.
59
Name - Mary [negatives], n.d.
59
Name - Bob [negatives], n.d.
56 224
Newborn 101, long term patching, 1976-1977
56 225
Newborn (NBM 2) eye patched [photographs, negative], n.d.
56 226
Newborn (NBM 5) control [photographs, negative], n.d.
56 227
Newborn (NBM-6) control [photographs, negative], n.d.
56 228
Newborn (NBM-I) control [photographs, negative], n.d.
56 229
Newborn puppies. antipyrine -- blood flow [photographs], n.d.
56 230
Nose -- photos [photographs], n.d.
57 1
Operational equation [photographs], n.d.
57 2
Parkinsonian syndrome [photographs, negatives], n.d.
57 3
Percentage dephosphorylation of [14C] DG-6-P at time F [photographs, negatives], n.d.
57 4
Phosphate [photographs, negative], n.d.
57 5
Postmortem changes in DG and metabolites [photographs, negative], n.d.
57 6
Rat -- normal controls -- LCGU [photographs], n.d.
57 7
Rat auditory structures LCGO, n.d.
57 8
Rat visual structure LCGU, enucleation [photograph], n.d.
57 9
Sciatic n. stimu. and DRG [photographs], n.d.
57 10
Subfornical organ [photograph, slide], n.d.
57 11
Subfornical organ vs. saline, A 11 and saralasin A11 [photograph], n.d.
57 12
Sugar [photographs], n.d.
57 13
T 86 changes in metabolic activity following stimu. of the ventral, n.d.
57 14
Thiomin section - rat spinal cord [photographs], n.d.
57 15
Windy -- photos [photographs, negative], n.d.
57 16
Wortz geometric design [photographs], n.d.
58
X-sympathetic stim. [negatives], n.d.
 
Autoradiographs, 1970-2003
61
Standards C14, Cold Brain, Puppy Lambda, Equilibrium study [48 autoradiographs], 1970-1985
61
Cat-1 and Cat-3 [19 autoradiographs], 1971
61
CBF Cat-1 through CBF Cat-6 [38 autoradiographs], 1971
61
EC-1 [1 autoradiograph], 1971
61
Rat X-2 [1 autoradiograph, 1971
61
C-1 through C-2 [3 autoradiographs], 1973
61
DG-101 through DG-122; HR-201 [29 autoradiographs], 1973, 1976
61
DG-201A through DG-216A - experiment documentation, 1973
61
DG-201A through DG-216A [19 autoradiographs], 1973
61
DGH3-test and DGH3-1 [4 autoradiographs], 1973
61
MG-5-6, 8-9, 12, 14-16 [8 autoradiographs], 1973
61
MG-101 through MG-114 [14 autoradiographs], 1973
61
MG-1-4, 7, 10, 13, 17, 18; Methyl glucose 10 minutes [10 autoradiographs], 1973, 1977
61
SC1 and SC1A [23 autoradiographs], 1973
61
SM-2 [stimulated squirrel monkey] [23 autoradiographs], 1973
61
SM-2A [stimulated squirrel monkey] [10 autoradiographs], 1973
61
SM-3 [stimulated rhesus monkey] [11 autoradiographs], 1973
61
SM-4A [stimulated monkey] [18 autoradiographs], 1973
62
SR-1 through SR-5 [visual experiment]; SSR-1 through SSR-4 [sciatic nerve stimuli]; AUD-test and 2 through AUD-4 [auditory experiment] [24 autoradiographs], 1973-1974
62
ARF-1 through ARF-16 [CBF antiyprene] [18 autoradiographs], 1974
62
Monkey and rat intestines [1 radiograph], 1974
62
SM-3A [stimulated rhesus monkey] [19 autoradiographs], 1974
62
SM-5 [stimulated rhesus monkey] [16 autoradiographs], 1974
62
SM-6 [stimulated rhesus monkey] - experiment documentation, 1974
62
SM-6 [stimulated rhesus monkey] [28 autoradiographs], 1974
62
SM-7 [stimulated monkey] [5 autoradiographs], 1974
62
SM-8A [stimulated rhesus monkey] [13 autoradiographs], 1974
62
SM-9A [stimulated rhesus monkey] [11 autoradiographs], 1974
62
SM-10 [stimulated monkey] [21 autoradiographs], 1974
62
SM-11 [stimulated rhesus monkey] [13 autoradiographs], 1974
62
SM-12 [stimulated rhesus monkey] [13 autoradiographs], 1974
62
SM-13 [stimulated rhesus monkey] [26 autoradiographs], 1974
62
AR-1 through AR-13 [anesthesia studies] [16 autoradiographs], 1974-1975
63
CR-1-5, 101-105; CB-4-7, 9; CRF-201; C02 5 percent [22 autoradiographs], 1974-1976
63
CRF-2-15, 101-105, 111-115 [33 autoradiographs], 1974-1975
63
FD1 [1 radiograph], 1975
63
GBL-12 through GBL-15 [4 autoradiographs], 1975
63
GL1 Cat [8 autoradiographs], 1975
63
MTZ-2 [2 autoradiographs], 1975
63
PEN-1 through PEN-3 [penicillin seizure studies] [3 autoradiographs], 1975
63
Pen Cat-1 [8 autoradiographs], 1975
63
SLC-1 through SLC-2 [15 autoradiographs], 1975
63
SM-14 [stimulated rhesus monkey] [16 autoradiographs], 1975
63
SM-15 [stimulated rhesus monkey] [22 autoradiographs], 1975
63
SM-16 [stimulated rhesus monkey] [32 autoradiographs], 1975
63
SM-17 [stimulated rhesus monkey] [29 autoradiographs], 1975
63
SM-18 [stimulated rhesus monkey] [23 autoradiographs], 1975
64
SM-19 [stimulated rhesus monkey] [19 autoradiographs], 1975
64
SM-20 [stimulated rhesus monkey] [16 autoradiographs], 1975
64
SM-21 [stimulated rhesus monkey] [20 autoradiographs], 1975
64
SM-22 [stimulated rhesus monkey] [22 autoradiographs], 1975
64
WB-6-10, 13, 19 [13 autoradiographs], 1975
64
KSA-101-102, 104-111; KSH-1 through KSH-10; KSM-101 through KSM-102 [Kety-Schmitt assay] [16 autoradiographs], 1975-1976
64
LSD-DG-1-4, 1-13, 101-105, 151-153, 201-205, 301-305, 301-303, 401-407, 501-504, 601-603, 701 [57 autoradiographs], 1975-1976
64
MR, MA, MN, NAL, OIL - experiment documentation, 1975-1976
64
MR-1-8, 101-104, 202-204; MA-2 through MA-6; MN-1 through MN-6; NAL-1 through NAL-6; OIL-1 through OIL-2 [morphine active chronic - naloxone] [45 autoradiographs], 1975-1976
65
REM Cat-1 through REM Cat-3 [23 autoradiographs], 1975-1976
65
End-1 through End-12 [endorphins] [12 autoradiographs], 1976
65
End NC-1 through End NC-6 [6 autoradiographs], 1976
65
IOD Cat-1 through IOD Cat-2 [7 autoradiographs], 1976
65
IOD Cat-1 through IOD Cat-2 [8 autoradiographs], 1976
65
IOD Cat-3 [9 autoradiographs], 1976
65
IOD Cat-4 [6 autoradiographs], 1976
65
IOD Cat-5 [9 autoradiographs], 1976
65
IOD Cat-6 [8 autoradiographs], 1976
65
IOD Cat-7 [7 autoradiographs], 1976
65
IOD gamma-1 through IOD gamma-13; cold brain [15 autoradiographs], 1976
65
IODO-1 through IODO-6; Antipyrine-1 through Antipyrine-6 and trial [13 autoradiographs], 1976
65
NBM-1 [new born monkey] [18 autoradiographs], 1976
65
NBM-2 [new born monkey] [16 autoradiographs], 1976
65
NBM-3 [new born monkey] [15 autoradiographs], 1976
65
NBM-4 [new born monkey] [15 autoradiographs], 1976
65
NBM-5 [new born monkey] [16 autoradiographs], 1976
65
NBM-6 [new born monkey] [17 autoradiographs], 1976
65
NBM-7 [new born monkey] [17 autoradiographs], 1976
65
NBM-8 [new born monkey] [17 autoradiographs], 1976
65
NBM-101 [new born monkey] [22 autoradiographs], 1976
66
Piridine#1 [1 radiograph], 1976
66
REM Cat-4 and SLC-6 [11 autoradiographs], 1976
66
REM Cat-5 - experiment documentation, 1976
66
REM Cat-5 [7 autoradiographs], 1976
66
SM-23 [stimulated rhesus monkey] [18 autoradiographs], 1976
66
SM-24 [stimulated rhesus monkey] - experiment documentation, 1976
66
SM-24 [stimulated rhesus monkey] [14 autoradiographs], 1976
66
SM-25 [stimulated rhesus monkey] [15 autoradiographs], 1976
66
SM-27 [stimulated rhesus monkey] [21 autoradiographs], 1976
66
SM-28 [stimulated rhesus monkey] [31 autoradiographs], 1976
66
SM-29 [stimulated monkey] [24 autoradiographs], 1976
66
SM-30 [stimulated monkey] [23 autoradiographs], 1976
66
ADR-1 through ADR-12; PRP-0 through PRP-13; PH-0 through PH-14; L-ALP-3 through L-ALP-6; CSPE-1 through CSPE-4; PPE-1 through PPE-6; PRP and PH-1; SOT-1 through SOT-3; D-PRP-0 through D-PRP-4; L-PRP-0 through L-PRP-4 [74 autoradiographs], 1976-1977
66
D-AMP-1-8, 101, 103-109; L-AMP-1-7, 101-105; HLNC-1 through HLNC-15 [42 autoradiographs], 1976-1977
67
CS-1 through CS-27; D-1; CSO-2; C-DEX-1; DEX-1 through DEX-4 [control saline] [43 autoradiographs], 1976-1979
67
CS, YOH, DEX, PH, D-AMP, PX - experiment documentation, 1976-1979
67
CS-23; YOH-1 and 14; DEX-5; PH-2 and 6; D-AMP-102; PX-12, 14, 16, 21 [20 autoradiographs], 1976-1979
67
DG-136, 148, 167-168, 172, 174-181, 187-189; Tail-1 through Tail-6 [41 autoradiographs], 1976-1978
67
DG-124-135, 137-138, 142-145, 149-151, 154-158, 163, 165-166, 171, 173; PH9; FRD-3 [38 autoradiographs], 1976-1978
67
AR-1 through AR-6, AR-8 [aged rats] [10 autoradiographs], 1977
67
Cat-101 through Cat-105 [39 autoradiographs], 1977
67
CBS-4 through CBS-6; CS-1 through CS-2 [8 autoradiographs], 1977
67
DGX; DG [58 autoradiographs], 1977
67
Fetal sheep - experiment documentation, 1977
67
Fetal sheep-1 through 6, and 8-13 [14 autoradiographs], 1977
68
Fetal sheep-3 - experiment documentation, 1977
68
Fetal sheep-3 [10 autoradiographs], 1977
68
Free moving-1 [free moving vs. N20 bag rats] [1 radiograph], 1977
68
Free moving-1 through Free moving-9; N20 bag-1 through N20 bag-8 [free moving vs. N20 bag rats] [26 autoradiographs], 1977
68
HIG-1 through HIG-5 [normal control] [10 autoradiographs], 1977
68
IOD Cat-8 [7 autoradiographs], 1977
68
NC-1 through NC-6 [6 autoradiographs], 1977
68
NO-1 through NO-6; NOF-1 through NOF-6; Free moving-1 through Free moving-8 [nitrous oxide/free moving] [20 autoradiographs], 1977
68
One ear rat [3 autoradiographs], 1977
68
RBAA-18(test) [1 radiograph], 1977
68
RTAA1 [2 autoradiographs], 1977
68
SCD-KCL-1 through SCD-KCL-17; SCD-5; SCD-0-1, 2, 3, and 5; SCD-NACL-1; SCD-OK-1 through SCD-OK-15; SCD-OKF-1; SCD-F-1 through SCD-F-8 [spreading cortical depression] [50 autoradiographs], 1977
68
SM-31 [stimulated rhesus monkey] [20 autoradiographs], 1977
68
SM-32 [stimulated monkey] [22 autoradiographs], 1977
68
SM-33 [stimulated rhesus monkey] [16autoradiographs], 1977
68
SSM-1 [18 autoradiographs], 1977
68
SSM-2 [26 autoradiographs], 1977
68
SSM-3 [17 autoradiographs], 1977
68
SSM-4 [18 autoradiographs], 1977
69
ABS-1 through ABS-4; 1856-5 through 1856-8; Toxin-1, 12-14 [24 autoradiographs], 1977-1978
69
ARC-1 through ARC-8 - experiment documentation, 1977-1978
69
ARC-1 through ARC-8 [14 autoradiographs], 1977-1978
69
GS-1 through GS-17 [gastric secretion] [51 autoradiographs], 1977-1978
69
Harvard rat-1-7, 10, 13-17 [36 autoradiographs], 1977, 1979
69
MIK-1, 2, 5, 9-10; MAK-1, 6, 8-13; B-1, 2, 5, 7-9, 11-15 [44 autoradiographs], 1977-1978
69
SCD-20-1 and SCD-20-2; SCD-40-1 and SCD-40-2; SCD-M-1 through SCD-M-3; SCD-80-1; SCD-150-1 [spreading cortical depression] [22 autoradiographs], 1977-1978
69
DEX-1 through DEX-5; DEXT-PX-1 through DEXT-PK-5; Ph-8 [dextran] [31 autoradiographs], 1977-1979
70
A-9 [2 autoradiographs], 1978
70
ACL-1, 3, and 4; BCL-1 through BCL-4 [albino/pigmented rats continuous intense light exposure] [14 autoradiographs], 1978
70
ADVS-1 through ADVS-4; BDVS-1 through BDVS-4 [16 autoradiographs], 1978
70
AE, BE, ABE, BBE [albino/pigmented enucleation studies] - experiment documentation, 1978
70
AE-1 through AE-5; BE-1 through BE-5; ABE-1; BBE-1 [40 autoradiographs], 1978
70
Airbag-1 through Airbag-9 [air bag #8 normal control] [19 autoradiographs], 1978
70
AVS, BVS, ADR, MAK-TI, MAK-II - experiment documentation, 1978
70
AVS-0-1 through AVS-0-4, AVS-0-11 through AVS-0-14; BVS-0-1 through BVS-0-7; ADR-1 and ADR-11; MAK-TI-1 through MAK-TI-2; MAK-II-2 [45 autoradiographs], 1978
70
Cat Cord 1 (spinal cord and brain) [17 autoradiographs], 1978
70
CL-CT-1 [3 autoradiographs], 1978
70
Dee [36 autoradiographs], 1978
70
DG-182-186, 190-196, 198-199 [28 autoradiographs], 1978
71
Fetal sheep 221 [21 autoradiographs], 1978
71
Fetal sheep 228 - experiment documentation, 1978
71
Fetal sheep 228 [15 autoradiographs], 1978
71
Fetal sheep 244 - experiment documentation, 1978
71
Fetal sheep 244 [16 autoradiographs], 1978
71
GRC-10B [1 radiograph], 1978
71
GS-19-20, 22-33, 36-45 [gastric secretion] [75 autoradiographs], 1978
71
GS-27and GS-38 [2 autoradiographs], 1978
71
Lamb-1 through Lamb-2 [11 autoradiographs], 1978
71
MG-64 [2 autoradiographs], 1978
71
MSG-1 through MSG-7 [21 autoradiographs], 1978
72
MSG-6 [2 autoradiographs], 1978
72
NaCl-1 through NaCl-9; MSB-2, 4, 5; DG-170 [saline group] [34 autoradiographs], 1978
72
Phosphate-1 through Phosphate-32 [33 autoradiographs], 1978
72
Rocky-1 through Rocky-32 [stimulated monkey] [38 autoradiographs], 1978
72
SCD-80-1 through SCD-80-4; SCD-80-6 through SCD-80-10 [spreading cortical depression] [18 autoradiographs], 1978
72
SCD-V-1-0; SCD-V-1 through SCD-V-10; SCD-90-11; SCD-OK-21 through SCD-OK-22 [spreading cortical depression] [28 autoradiographs], 1978
72
Space Cat-A and Space Cat-B [2 autoradiographs], 1978
72
Stand VS-S-1 and Stand VS-3 [3 autoradiographs], 1978
72
Windy [33 autoradiographs], 1978
72
YOH-3-7, 10-13 [27 autoradiographs], 1978
72
Zieg-C [2 autoradiographs], 1978
72
ANL-1 through ANL-4; BNL-1 through BNL-4; AVS-1-4, 21-24, 31-34, 41-44; BVS-1-4, 21-24, 31-34, 41-44, 51-54 [85 autoradiographs], 1978-1979
73
APO-7, 13 - experiment documentation, 1978-1979
73
APO-7, 13 [31 autoradiographs], 1978-1979
73
APO-18-1 through APO-18-7; APO-C through APO-3C - experiment documentation, 1978-1979
73
APO-18-1 through APO-18-7; APO-C through APO-3C [38 autoradiographs], 1978-1979
73
DG-200-205, 207-217; CK-1 through CK-2 [43 autoradiographs], 1978-1979
73
SCG - experiment documentation, 1978-1979
73
BDSCG-1 and BDSCG-2; BSDSCG-1 and BSDSCG-2; BD2SCG-1 and BD2SCG-2; BD3SCG-1 and BD3SCG-2 [8 autoradiographs], 1978-1979
73
IHG-1 through IHG-8 [17 autoradiographs], 1978-1979
73
LIDO-1 through LIDO-13 [Lidocaine] [31 autoradiographs], 1978-1979
74
LIDO-1, 2, 5-13 [Lidocaine] [24 autoradiographs], 1978-1979
74
PX-0-9, 13-20, 22 [phenoxybenzomine] [52 autoradiographs], 1978-1979
74
SHR-4 [1 autoradiograph], 1978-1979
74
YOH-14 through YOH-29 [47 autoradiographs], 1978-1979
74
APO-4-1 through APO-4-12 - experiment documentation, 1979
74
APO-4-1 through APO-4-12 [33 autoradiographs], 1979
74
APO-28-1 through APO-28-6 - experiment documentation, 1979
74
APO-28-1 through APO-28-6 [27 autoradiographs], 1979
74
Cat- experiment documentation [2 folders], 1979
75
Cold brain w/ hot holes - experiment documentation, 1979
75
Cold brain w/ hot holes -1 and 2 [7 autoradiographs], 1979
75
DG-206, 216-217 [16 autoradiographs], 1979
75
DX-1 [glycerol perfused brain] [1 radiograph], 1979
75
GC-1 [2 autoradiographs], 1979
75
Gee [32 autoradiographs], 1979
75
Harvard sleep rat-1 through Harvard sleep rat-4 [16 autoradiographs], 1979
75
HY, HYP, HY-CONT, HYR - experiment documentation [hypoxia (pigmented rats)], 1979
75
HY-1-6, 20-21, 601; HYP-1 through HYP-4; HY-7-9, 10-12, 21-26; HY-CONT-2-4, 6, 7; HYR-1 through HYR-2 [95 autoradiographs], 1979
76
HY-7 [1 radiograph], 1979
76
HY-cont-5 - experiment documentation, 1979
76
HY-cont-5 [3 autoradiographs], 1979
76
KK-1 [1 radiograph], 1979
76
Milt-1 through Milt-32 [32 autoradiographs], 1979
76
PCP-2 [2 autoradiographs], 1979
76
Reza [25 autoradiographs], 1979
76
Sugar-1 through Sugar-29 [30 autoradiographs], 1979
76
TOE-1 [toe stimulation] [6 autoradiographs], 1979
76
Acid - experiment documentation (23, 32), 1979-1980
76
Acid-1, 6-9, 16, 20, 22-26, 32-41; NOR-4 through NOR-5; Heart-10 through Heart-12 and Heart-18; CHO-13 [68 autoradiographs], 1979-1980
76
Landau [24 autoradiographs], 1979-1980
76
SCG - 1A5 through 4A5; 2A10 through 4A10; CA15; 1A15, 3A15, 4A15; 1A20 through 4A20 [15 autoradiographs], 1979-1980
77
Amanda - experiment documentation, 1980
77
Amanda; Amanda eyes; Amanda spinal cord [31autoradiographs], 1980
77
Atlas-1 [3 autoradiographs], 1980
77
BSL-1 and BSL-3 [2 autoradiographs], 1980
77
Cat 201 [8 autoradiographs], 1980
77
Cat 202 [10 autoradiographs], 1980
77
Cat 203 [10 autoradiographs], 1980
77
CSN-12 [17 autoradiographs], 1980
77
Dreamless - experiment documentation (3-6, 19-24), 1980
77
Dreamless -test, 2-29 [29 autoradiographs], 1980
77
Marley [37 autoradiographs], 1980
77
N2O-2 and N2O-4 [2 autoradiographs], 1980
77
OLF - experiment documentation, 1980
77
OLF-1 through OLF-2 [4 autoradiographs], 1980
77
Posh - experiment documentation (7-10, 13-15, 19-24), 1980
77
Posh -test, 1-10, 13-26 [26 autoradiographs], 1980
77
PRT-2 through PRT-4 [12 autoradiographs], 1980
78
Retina-1 through Retina-3 - experiment documentation, 1980
78
Retina-1 through Retina-3 [11 autoradiographs], 1980
78
Valium diazepam - experiment documentation [i.e. VALC, VALL, VALIUM, VAM, VALM], 1980
78
VALC-1 through VALC-8; VALL-1 through VALL-6; VALIUM-1, 2, 4 through 6; VAM-1 through VAM-6; VALM-3 and VALM-7 [70 autoradiographs], 1980
78
SCG-63, 65-66, 74, 76, 78, 80, 83, 101, 131; and CONT-1 and 2 [34 autoradiographs], 1980, 1983
78
HBC, LHB - experiment documentation, 1980-1981
78
HBC-1 through HBC-4; LHB-1, 3-8 [unilateral lesion of habenula] [31 autoradiographs], 1980-1981
78
HG-1-3, 5-6, 8-9, 12-15; LCGU-73; HPYGL-3; Hyper-74 [48 autoradiographs], 1980-1982
78
HG; HG-SCG; HG-Pit; HG-Ganglia; HGC; CO; Hyper - experiment documentation, 1980-1983
78
HG-3-10, 12-15; HG-SCG-27-32; HG-Pit-1-33; HG-ganglia-2, 3, 5, 6, 9-10, 12-15, 21-26; HGC-1-3; CO-1-2; Hyper-4-5 [73 autoradiographs], 1980-1983
78
MRC, MRH, MRM, MC, Morph, M10 - experiment documentation, 1980-1981
79
MRC-1 through MRC-2; MRH-1 through MRH-9; MRM-1 through MRM-6; MC-6; Morph cont-1 through Morph cont-5; Morph-1 through Morph-8; M10-1 through M10-6 [morphine low dose saline] [96 autoradiographs], 1980-1981
79